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Lipidation of proteins regulates many cellular processes such as signaling 
transduction and membrane sorting by modulating protein localization and protein-
protein interactions.  As such, defects in protein lipidation can render host cells more 
susceptible to microbial infection and are also associated with a variety of human 
diseases ranging from cancer to neurological disorders.  Moreover, viral and bacterial 
pathogens can exploit and modulate the host lipidation machinery to enhance infection.  
Robust biochemical methods for characterizing lipidated proteins are therefore important 
for understanding fundamental physiology and disease mechanisms.  In this thesis, I 
report the development of alkyne-lipid chemical reporters that afford more sensitive 
detection and proteomic analysis of fatty-acylated and prenylated proteins using 
bioorthogonal ligation methods.  Alkynyl-fatty acids of 14 and 18 carbons afforded 
enhanced detection of N-myristoylated and S-palmitoylated proteins, respectively, while 
alkynyl-farnesol allowed more robust analysis of S-prenylated proteins.  These new lipid 
chemical reporters enabled the discovery of bacterial virulence factors that are lipid-
modified by host enzymes during infection as well as lipidated host proteins (IFITM3 and 
ZAP) involved in cellular resistance to viruses.  My thesis work highlights the utility of 
alkyne lipid reporters for biochemical analysis of lipidated proteins at the host-pathogen 
interface that will hopefully help other biological studies. 
 iii 
 
ACKNOWLEDGMENTS 
I wish to express my gratitude to all those who have supported me throughout my 
time at The Rockefeller University, as mentors, teachers, collaborators, colleagues and 
companions.  In particular, I thank 
First and foremost, my advisor and mentor Dr Howard Hang.  I am grateful for 
his guidance throughout the years and his rigorous efforts to train me into becoming an 
accomplished scientist.  He offered me invaluable insights into how to approach scientific 
problems, properly design experiments to address the questions, appropriately interpret 
the results, and efficiently report our findings in acclaimed peer-reviewed journals.  Since 
I was the second graduate student to join his laboratory, he also offered me the 
opportunity to have a glance at the rewards and difficulties in setting-up a laboratory and 
starting an independent scientist career. All of these will guide me positively throughout 
my own personal profession. 
Dr Tarun Kapoor, who as the chair of my thesis committee dutifully followed my 
progress over the course of my studies and helped me keep a clear picture of my own 
goals.  His care and criticism were always appreciated. 
 Dr Hening Lin, for his excellent course that introduced and fascinated me with the 
intricacies of protein post-translational modifications.  This certainly influenced me to 
later on join Dr Hang’s research group and I thank him for this and for being a member of 
my thesis committee. 
 iv 
 
 Dr Stephen Goff, the external member of my thesis committee, who showed 
immediate interest in my research.  I am honored to have as an examiner the scientist 
who discovered ZAP, a protein that I studied in this thesis. 
 Dr Margaret Macdonald and Dr Melody Li, for their enthusiasm in the 
collaboration on the ZAP project.  Working with them was stimulating and appreciated, 
and I thank them for taking the time to train me for the experiments with viruses. 
 Dr Haiteng Deng and the staff of The Rockefeller Proteomics Resource Center for 
streamlining the mass spectrometry analysis. 
 Members of the Hang research group for sharing advice and reagents, and for 
stimulating conversations. I would like to especially thank: Dr Jacob Yount, Dr John 
Wilson and Dr Mingzi Zhang for their availability and prevalence in my initial training in 
biological methods; Dr Kelvin Tsou, Dr Yu-Ying Yang and Dr Anuradha Raghavan for 
their interest in organic chemistry discussions; and all other lab members for the great 
interdisciplinary atmosphere of the laboratory. 
 The Weill Cornell / Rockefeller / Sloan-Kettering Tri-Institutional Training 
Program in Chemical Biology for funding and giving me the opportunity to study abroad. 
 My family and friends, whose support and encouragements have been invaluable. 
  
 v 
 
TABLE OF CONTENTS 
	
CHAPTER I.  Introduction ................................................................................................. 1 
1.1 Membrane targeting of lipidated proteins ................................................................. 1 
1.2 Protein fatty-acylation in eukaryotes ......................................................................... 5 
1.3 Protein prenylation in eukaryotes .............................................................................. 7 
1.4 Protein lipidation in host-pathogen interactions ........................................................ 9 
1.5 Chemical reporters for studying protein lipidation in cells ..................................... 13 
CHAPTER II. Chemical reporters of protein fatty-acylation ........................................... 16 
2.1 Alkynyl-fatty acids synthesis .................................................................................. 16 
2.2 Alkynyl-fatty acids characterization ....................................................................... 18 
2.2.1 Comparative analysis of bioorthogonal labeling methods ............................... 18 
2.2.2 Specificity and generality of fatty-acylated protein labeling with chemical 
reporters ..................................................................................................................... 22 
2.3 Application of fatty acid chemical reporters ........................................................... 35 
CHAPTER III. Chemical reporters of protein prenylation ............................................... 38 
3.1 Alkynyl-isoprenoids synthesis ................................................................................ 38 
3.2 Alkynyl-isoprenoids characterization ..................................................................... 40 
3.2.1 Comparative analysis of bioorthogonal labeling methods ............................... 40 
3.2.2 Specificity and generality of prenylated protein labeling with chemical 
reporters ..................................................................................................................... 42 
3.2.3 Detection of prenylated bacterial effector ........................................................ 44 
3.3 Proteomic identification of prenylated proteins ...................................................... 51 
3.3.1 Synthesis of cleavable linker azido-azo-biotin for proteomic analysis ............ 51 
3.3.2 Proteomic analysis of prenylated proteins in RAW264.7 macrophages .......... 53 
3.4 S-farnesylation is crucial for membrane targeting and antiviral activity of zinc-
finger antiviral protein long-isoform (ZAPL) ............................................................... 61 
3.4.1 Long-isoform of ZAP is S-farnesylated ............................................................ 64 
3.4.2 S-farnesylation controls membrane targeting and cellular localization of ZAPL
 ................................................................................................................................... 66 
 vi 
 
3.4.3 S-farnesylation regulates ZAPL antiviral activity ............................................ 71 
CHAPTER IV. Discussion................................................................................................ 75 
4.1 Improvements in detection of lipidated proteins ..................................................... 75 
4.2 Current limitations of lipid chemical reporters ....................................................... 76 
4.3 Analysis of SifA prenylation in cells ...................................................................... 77 
4.4 Analysis of isoform-specific farnesylation of ZAPL .............................................. 78 
CHAPTER V. Experimental methods .............................................................................. 80 
5.1 Plasmids construction .............................................................................................. 80 
5.2 Cell culture, transfections and metabolic labeling .................................................. 80 
5.2.1 Alkynyl-fatty acid in vivo labeling in mice ...................................................... 81 
5.3 Immunoprecipitation ............................................................................................... 82 
5.4 Bioorthogonal ligation ............................................................................................. 83 
5.4.1 Staudinger ligation ............................................................................................ 83 
5.4.2 CuI-catalyzed azide-alkyne cycloaddition (CuAAC) ....................................... 83 
5.5 Hydroxylamine cleavage of S-acylated proteins ..................................................... 84 
5.6 In-gel fluorescence imaging .................................................................................... 85 
5.7 Immunoblotting ....................................................................................................... 85 
5.8 Prenylome profiling ................................................................................................. 86 
5.8.1 Enrichment of alk-FOH labeled proteins .......................................................... 86 
5.8.2 LC-MS/MS analysis ......................................................................................... 87 
5.8.3 Database searching ........................................................................................... 87 
5.8.4 Criteria for protein identification ...................................................................... 88 
5.9 Microscopy .............................................................................................................. 88 
5.10 Virus infections and flow cytometry ..................................................................... 89 
5.11 Synthesis of chemical reporters and secondary tags ............................................. 90 
5.11.1 General procedures ......................................................................................... 90 
5.11.2 Alkynyl-fatty acids synthesis.......................................................................... 90 
5.11.3 Alkynyl/azido-isoprenoids synthesis .............................................................. 91 
5.11.4 Biotin detection tag synthesis ......................................................................... 97 
5.11.5 Rhodamine detection tags synthesis ............................................................... 98 
5.11.6 Azido-azo-biotin cleavable tag for proteomics synthesis ............................... 99 
 vii 
 
5.12 1H and 13C NMR spectra ..................................................................................... 102 
CHAPTER VI. Bibliography .......................................................................................... 143 
 
  
 viii 
 
LIST OF FIGURES 
Figure 1: Survey of protein lipidation in eukaryotes. ......................................................... 4 
Figure 2: Protein fatty-acylation. ........................................................................................ 6 
Figure 3: Protein prenylation. ............................................................................................. 8 
Figure 4: Lipidated proteins analysis using bioorthogonal ligation reactions. ................. 14 
Figure 5: Synthesis of alkynyl-fatty acids and secondary detection tags. ........................ 17 
Figure 6: Biochemical analysis of chemical reporters for protein fatty-acylation in 
mammalian cells. .............................................................................................................. 20 
Figure 7: Biochemical analysis of chemical reporters for protein fatty-acylation in 
mammalian cells. .............................................................................................................. 21 
Figure 8: Specificity of alkynyl-fatty acids labeling in cells. ........................................... 24 
Figure 9: Specificity of alkynyl-fatty acids labeling in cells. ........................................... 25 
Figure 10: Specificity of alkynyl-fatty acids labeling in cells. ......................................... 26 
Figure 11: Robust visualization of fatty-acylated proteins after immunoprecipitation. ... 28 
Figure 12: Robust visualization of fatty-acylated proteins after immunoprecipitation. ... 29 
Figure 13: Profile of fatty-acylated proteomes in different cell lines and mouse tissues.  32 
Figure 14: Profile of fatty-acylated proteomes in mouse tissues. ..................................... 34 
Figure 15: Synthesis of prenylation reporters. .................................................................. 39 
Figure 16: Comparative analysis of prenylation reporters. ............................................... 41 
Figure 17: Fluorescent visualization of protein S-prenylation on known prenylated 
proteins and in different cell types. ................................................................................... 43 
Figure 18: Detection of prenylation of Salmonella SifA bacterial effectors prenylation. 46 
Figure 19: Detection of prenylation of Legionella bacterial effectors prenylation. ......... 49 
Figure 20: Synthesis of azido-azo-biotin. ......................................................................... 52 
Figure 21: Visualization and identification of prenylated proteins in RAW264.7 
macrophages. .................................................................................................................... 55 
Figure 22: ZAP is S-farnesylated of Cys993. ................................................................... 63 
Figure 23: S-farnesylation of Cys993 excludes murine ZAPL from the cytosol. ............. 65 
Figure 24: S-Farnesylation-dependent clustering of ZAPL to endo/lysosomes. .............. 67 
Figure 25: S-Farnesylation-dependent clustering of ZAPL with lysosomes. ................... 68 
Figure 26: S-Farnesylation-dependent clustering of ZAPL with late endosomes. ........... 69 
Figure 27: S-Farnesylation does not cluster ZAPL with early endosomes. ...................... 70 
Figure 28: Antiviral activity of ZAPL is regulated by S-farnesylation. ........................... 73 
Figure 29: Antiviral activity of ZAPL is regulated by S-farnesylation. ........................... 74 
 
  
 ix 
 
LIST OF TABLES 
Table 1: Survey of lipidated viral proteins. ...................................................................... 10 
Table 2: Survey of lipidated bacterial effectors. ............................................................... 11 
Table 3: Proteins selectively identified with high confidence in alk-FOH samples by mass 
spectrometry. ..................................................................................................................... 57 
Table 4: Proteins selectively identified with medium confidence in alk-FOH samples by 
mass spectrometry. ............................................................................................................ 59 
 
 
 1 
 
CHAPTER I.  Introduction 
 Post-translational lipidation of proteins is an important mechanism to regulate 
protein trafficking and activity in eukaryotes[1].  Targeting of proteins to membranes by 
lipidation plays key roles in many physiological processes and when not regulated 
properly can lead to cancer[2] and neurological disorders[3].  Dissecting the precise roles 
of protein lipidation in physiology and disease is a major challenge, but recent advances 
in chemical biology have now afforded new chemical reporters of protein lipidation that 
have improved the detection and analysis of lipidated proteins[4-6].  In this thesis, I 
report the development of alkynyl-lipids as improved chemical reporters of protein fatty-
acylation[7] and prenylation[8], and their application towards the characterization of 
lipid-mediated host-pathogen interactions[8-12]. 
1.1 Membrane targeting of lipidated proteins 
Eukaryotic cell membranes are composed of a vast assortment of amphipathic 
lipids, which consist of a hydrophobic and a hydrophilic portion.  The hydrophobic 
moieties are entropically driven by water to self-associate, while the hydrophilic moieties 
interact with aqueous environments and with each other, which is the physical basis for 
the spontaneous formation of membrane bilayers[13].  Membranes thus allow for the 
segregation of the cell’s content from its external environment (plasma membrane) and 
the further compartmentalization of the content of discrete intracellular organelles 
(endoplasmic reticulum (ER), Golgi apparatus, endocytic vacuoles, etc.) where specific 
chemical reactions are isolated for increased biochemical efficiency and restricted 
dissemination of reaction products[13].   
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Recent advances in mass spectrometry have revealed the existence of >1,000 
different lipid species in eukaryotic cells arising from the variations in headgroups and 
aliphatic chains[14].  In cells, membrane lipids can adopt various fluid and solid phases 
depending on their structure and environment.  These phases have specific properties that 
determine the spatial arrangement and motional freedom of membrane lipids and 
proteins, and will therefore affect membrane functionality[15].  The adopted phase 
depends on lipid structure: long, saturated hydrocarbon chains (as found in sphingolipids) 
tend to adopt solid-like phases due to their efficient packing; while cis-unsaturated 
hydrocarbon chains (most phosphatidylcholine (PtdCho) molecules have one) tend to be 
enriched in liquid phases where cis-unsaturations impose a conformational constraint 
preventing optimal alignment of lipid chains.  When combined with sphingolipids, 
cholesterol has the remarkable ability of forming a liquid-ordered phase that has the high 
order of a solid but the high translational motility of a liquid[16].  Moreover, PtdCho plus 
cholesterol can adopt two coexisting fluid phases: liquid-ordered and liquid-
disordered[17].  The coexistence of two fluid phases with different physical 
characteristics within a single membrane plane creates energetically unfavorable phase 
boundaries where some membrane proteins cluster to decrease the line energy (tension) 
between domains[18]. 
Diverse lipid compositions of each organelle membranes are maintained through 
specific localized lipid metabolism and lipid transport, allowing distinct membrane 
biophysical properties and protein associations.  For example, the ER membrane 
composition (60 mol% PtdCho, 25 mol% phosphatidylethanolamine (PE) and 10 mol% 
phosphatitylinositol (PI)) results in loose lipid packing while the plasma membrane 
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composition (25 mol% PI, 15 mol% PE, 30-40 mol% cholesterol, 10 mol% sphingolipids 
and 5 mol% phosphatidylserine) allows for the formation of ordered cholesterol-rich 
lipid-protein microdomains which can be stabilized to function in membrane trafficking 
and signaling[19].  Protein association to specific membranes is dictated by various 
hydrophobic domains and/or lipid modifications.  These lipid modifications include 
glycophosphatidylinositol (GPI) anchors, cysteine fatty-acylation, N-terminal 
myristoylation, and C-terminal isoprenylation (Figure 1).  Evidence suggests that 
modification by long saturated lipids (GPI anchors and palmitoylation) recruits both 
peripheral and transmembrane proteins to ordered lipid domains, while short, unsaturated 
and/or branched hydrocarbon chain modifications (such as myristoylation and 
isoprenylation) prevent such association[20]. 
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1.2 Protein fatty-acylation in eukaryotes 
 Fatty-acylated proteins are synthesized by discrete families of acyltransferases 
that utilize fatty acid–CoA substrates to yield cytoplasmic proteins that are N-
myristoylated[21] or S-palmitoylated[22] as well as secreted proteins that can be S-, N-, 
or O-acylated[23-24] (Figure 1).  N-Myristoyltransferases (NMTs, 2 in mammals, 1 in 
yeast) catalyze the transfer of myristic acid to N-terminal glycine residues of proteins 
bearing the GXXXS/T consensus sequence (Figure 2a)[21].  Alternatively the DHHC–
protein acyltransferases (DHHC–PATs, ~23 in mammals, 7 in budding yeast) install 
palmitic acid onto cysteine residues of proteins (Figure 2b)[22].  In comparison to N-
myristoylation, DHHC-PAT-mediated S-palmitoylation has no defined amino acid 
consensus sequence and S-palmitoylation sites are often modified with a heterogeneous 
composition of fatty acids.  Moreover, S-palmitoylation is reversible, modulated by 
cellular stimulation and regulated by yet uncharacterized lipases[22], which suggests the 
S-acylation cycle may be particularly important for regulating dynamic processes in cells.  
Indeed, S-palmitoylation of N-myristoylated or S-prenylated proteins is typically required 
for stable membrane targeting of many proteins[1].  While many fatty-acylated proteins 
have been identified and are associated with various cellular pathways, their specific 
functions and mechanisms of regulation in physiology and disease remain to be explored.
  
Figure 2: Protein fatty-acylation. (a) N-myristoylation.  (b) DHHC-mediated S-palmitoylation. 
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1.3 Protein prenylation in eukaryotes 
Protein prenylation encompasses S-farnesylation and S-geranylgeranylation 
(Figure 1), which are catalyzed by farnesyltransferase (FTase) and 
geranylgeranyltransferase I and II (GGTase I and GGTase II), respectively[25].  FTase 
and GGTase I transfer farnesyl pyrophosphate and geranylgeranyl pyrophosphate, 
respectively, onto the C-terminus of proteins that contain a C-terminal CaaX motif, where 
C is the modified cysteine, ‘a’ are often aliphatic amino acids and X represents an amino 
acid that determines specificity for the prenyltransferase.  For example, X is frequently 
Met, Gln, or Ser for FTase, and Leu or Phe for GGTase I, whereas some CaaX motif 
proteins are substrates for both prenyltransferases.  Following S-prenylation, the 
endopeptidase Ras converting enzyme 1 (RCE1) cleaves the tripeptide (aaX) to reveal a 
C-terminal cysteine that is subsequently methylated by isoprenylcysteine carboxyl 
methyltransferase (ICMT) (Figure 3a).  In contrast, GGTase II (also called RabGGTase), 
a structurally and functionally different prenyltransferase, dually S-geranylgeranylates the 
family of Rab proteins at their C-terminal cysteine residues (Figure 3b).  RabGGTase 
substrate specificity is not dictated by a consensus sequence but by Rab escort proteins 
(REPs) that bind Rab proteins and target them for enzymatic modification[25].  The 
largest group of S-prenylated proteins is the Ras superfamily of GTPases that 
encompasses the Ras, Rho/Rac and Rab subfamilies of proteins, which play critical 
regulatory roles in a variety of cellular processes, from cellular signaling to immune 
system functions[26]. 
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1.4 Protein lipidation in host-pathogen interactions 
 Viral and bacterial pathogens evolved an array of mechanisms to subvert and 
exploit host immune systems for effective infection and replication[27].  Viruses gain 
entry into cells by exploiting specific lipid receptors to bind host cells and induce changes 
in membrane properties, which results in endocytosis and intracellular transport of 
viruses to their site of replication[28].  Several of these viral proteins exploit the host 
post-translational machinery to gain lipid anchors that regulate their function, membrane 
association and localization in the cell (Table 1).  For example, HIV-1 Gag protein 
multimerization[29], influenza virus M2 protein lipid raft targeting[30], and large 
hepatitis delta antigen viral assembly[31] require myristoylation, palmitoylation and 
farnesylation, respectively. 
Intracellular bacterial pathogens secrete effector proteins into host cells which co-
opt host signaling pathways[32], subvert membrane transport pathways[33] and remodel 
host cellular membranes[34] to facilitate entry and evade lysosomal degradation.  Several 
of these bacterial effectors also make use of the host protein lipidation machinery to 
regulate their localization and function in the cell (Table 2).  For example, 
myristoylation-dependent targeting to the host plasma membrane of Avr proteins from 
Pseudomonas syringae enhances their virulence function[35].  Palmitoylation and 
prenylation of Salmonella typhimurium SifA[36], and prenylation of Legionella 
pneumophila[37-38] effectors is required to target them to the bacteria-containing 
vacuoles and promote infection. Pathogens thus utilize host-specific protein post-
translational lipidation to access the subcellular compartments where they function.
  
 
Table 1: Survey of lipidated viral proteins. 
Protein Name Viruses Modification 
Site of 
lipidation 
Sequence 
Nef Lentiviruses (HIV, SIV) N-myristoylation 2 MGGKWS- 
Gag Retroviruses, Poxviruses N-myristoylation 2 MGQIFS- 
Large surface 
antigen 
Hepatitis B virus N-myristoylation 2 MGQNLS- 
v-Src Rous sarcoma virus N-myristoylation 2 MGSSKS- 
B5 Vaccinia virus S-palmitoylation 301,303 -VCSCD- 
M2 Influenza virus S-palmitoylation 50 -FKCIY- 
CM2 Influenza C virus S-palmitoylation 324 -RWCGD- 
MIR2 Kaposi's sarcoma-associated herpes virus S-palmitoylation 146 -GICRV- 
Large delta antigen Hepatitis delta virus S-farnesylation 211 -CRPQ 
Us2 Pseudorabies virus S-prenylation 253 -CTIS 
10
  
 
Table 2: Survey of lipidated bacterial effectors. 
Protein Name Bacteria Modification Site of lipidation Sequence 
AvrRpm1 Pseudomonas syringae N-myristoylation 2 MGCVSS- 
AvrB Pseudomonas syringae N-myristoylation 2 MGCVSS- 
AvrPto Pseudomonas syringae N-myristoylation 2 MGNICV- 
AvrPphB Pseudomonas syringae N-myristoylation 63 -KGCASS- 
AvrPphB Pseudomonas syringae S-palmitoylation 64 -KGCASS- 
SifA Salmonella typhimurium S-palmitoylation 331 -CLCCFL 
SifA Salmonella typhimurium S-geranylgeranylation 333 -CLCCFL 
AnkB Legionella pneumophila S-farnesylation 169 -CVLC 
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 Protein lipidation also regulates innate or adaptive immunity in plant and animals.  
For example, specific recognition of Pseudomonas syringae effector proteins AvrPto and 
AvrPtoB in tomato plants by Pto kinase and subsequent induction of defense responses is 
mediated by Pto myristoylation[39]. In mammalian cells, the initiation and propagation 
of T cell signaling requires the organization of receptors and signaling proteins such as 
CD4 and CD8 co-receptors, Src-family kinases, and the adaptor protein LAT, which are 
localized to lipid rafts due to their palmitoylation[40].  Prenylation of the Ras superfamily 
of GTPases is required for receptor-mediated activation, cell migration and membrane 
transport in mammalian cells through the Ras, Rho and Rab proteins, respectively[26].  
Robust detection of lipidated proteins is challenging and improved detection methods 
would allow for further characterization of protein lipidation in host-pathogen 
interactions.
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1.5 Chemical reporters for studying protein lipidation in cells 
 Protein lipidation in cells has historically been visualized by metabolic labeling 
with radioactive (3H, 14C) lipids followed by autoradiography of labeled proteins[41].  
While effective, radioactivity often requires long exposure times and is hazardous[41-42].  
The development of bioorthogonal labeling reactions (Figure 4a,b) and chemical 
reporters (azide-modified lipids, Figure 4c)[43] has provided improved methods for the 
detection of protein lipidation in cells (Figure 4d).  For example, an azide-derivative of 
farnesol (az-FOH, Figure 4c) can be utilized by mammalian cells, installed onto 
prenylated proteins and readily visualized by streptavidin blot after reaction with 
phosphine–biotin reagents via the Staudinger ligation[44] (Figure 4a).  Likewise, azido-
fatty acids (az-12 and az-15, Figure 4c) can be metabolically incorporated onto N-
myristoylated or S-palmitoylated proteins depending on their chain length and readily 
visualized after bioorthogonal labeling with secondary detection tags[45] (Figure 4d).  
Shorter fatty acid chemical reporter (az-12) preferentially labels N-myristoylated 
proteins, while longer chain analog (az-15) selectively targets S-palmitoylation[45-47] 
(Figure 4c).  It should be noted that protein fatty-acylation in cells is heterogeneous, as 
some S-palmitoylated proteins are labeled with shorter and longer chain fatty acids.  
These fatty acid chemical reporters can also be utilized to detect the lipidation of secreted 
proteins such as Wnts[48]. 
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Azido-lipids/phosphine-biotin provides a convenient means to visualize 
prenylated and fatty-acylated proteins; however, immunoblotting methods are not ideal 
for analyzing quantitative changes in protein lipidation necessary for investigating 
dynamics or regulatory mechanisms.  Advances in bioorthogonal labeling methods 
employing the copper-catalyzed azide/alkyne cycloaddition[49-51] (CuAAC, Figure 4b) 
suggested an opportunity to improve the analysis of lipidated proteins with chemical 
reporters.  As with the Staudinger ligation, background labeling does occur in the 
CuAAC reaction when the alkyne reagent is present in excess, but significantly lower 
levels of non-specific reaction occur when the azide partner is employed in high 
concentration[52].  Thus, for the analysis of lipidated proteins, it would be advantageous 
to use lipid analogs that incorporate alkyne functional groups so that subsequent labeling 
could be performed with the more selective azide-containing reagent present in excess.  
In this thesis, I report the robust fluorescent detection of fatty-acylated and prenylated 
proteins with alkynyl-lipid chemical reporters that enable rapid biochemical analysis as 
well as proteomics of protein lipidation in mammalian cells. 
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CHAPTER II. Chemical reporters of protein fatty-acylation 
I synthesized a series of alkynyl-fatty acids of different lengths as potential 
chemical reporters as well as a panel of biotinylated (alk-biotin, az-biotin) and 
fluorescent (alk-rho, az-rho) detection tags to explore the detection of fatty-acylated 
proteins with CuAAC (Figure 5). 
2.1 Alkynyl-fatty acids synthesis 
 To generate gram quantities of alkynyl-fatty acids, I envisioned using the alkyne 
zipper reaction[53] to isomerize the internal alkyne of an acetylenic alcohol into a 
terminal alkyne followed by oxidation of the alcohol to the carboxylic acid (Figure 5a).  
Selective C-alkylation of dilithiated propargyl alcohol with different lengths of alkyl 
halides in liquid ammonia using lithium amide as the base afforded internal alkynyl 
alcohols (1, 2, 3) in good yields (93-97%, Figure 5a).  Isomerization of the internal 
alkyne to the terminal position was accomplished via lithium wire and potassium tert-
butoxide in 1,2-diaminopropane (70-78%, Figure 5a).  Finally, the desired alkynyl-fatty 
acids (alk-12, alk-14 and alk-16) were obtained after Jones oxidation (68-70%, Figure 
5a).
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 Secondary reaction tags for CuAAC were also synthesized.  Azido-biotin (az-
biotin) tag was obtained by coupling pegylated biotin[54] with 6-azidohexanoic acid 
chloroformate (45%, Figure 5b).  The synthesis of fluorescent azide/alkyne tags was 
based on the efficient functionalization of Rhodamine B to the rhodamine-piperazine 
amide derivative[55].  Multigram quantities of these water-soluble fluorophores can be 
prepared from inexpensive precursors and purified without the use of chromatography.  
Rhodamine-piperazine amide was then acylated via carbonyldiimidazole transacylation 
with either 6-heptynoic acid to generate alkynyl-rhodamine (alk-rho, 76%, Figure 5c) or 
6-azidohexanoic acid to yield azido-rhodamine (az-rho, 70%, Figure 5c). 
2.2 Alkynyl-fatty acids characterization 
2.2.1 Comparative analysis of bioorthogonal labeling methods 
Comparative analysis of the Staudinger ligation and CuAAC reaction with azido-
fatty acid-labeled cell lysates and biotinylated detection probes (phos-biotin and alk-
biotin, respectively) revealed significantly improved detection of fatty-acylated proteins 
by streptavidin blotting with CuAAC (Figure 6a).  We then investigated whether the 
orientation of alkyne and azide functional groups would influence the overall sensitivity 
of fatty-acylated protein analysis using CuAAC.  Cells were metabolically labeled with 
azide- or alkynyl-analogues of myristic acid (az-12, alk-12) or palmitic acid (az-15, alk-
14, alk-16) and assayed for the specific detection of fatty-acylated proteins in cell lysates 
using biotin (alk-biotin, az-biotin) or fluorescence (alk-rho, az-rho) detection tags and 
streptavidin blotting (Figure 6b) or in-gel fluorescence scanning (Figure 7a), respectively.  
Profiles of fatty-acylated proteins visualized by in-gel fluorescence scanning revealed 
substantially more proteins compared to streptavidin blotting, particularly with the 
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palmitic acid analogues (az-15, alk-14 and alk-16).  Like their azide counterparts, the 
alkynyl-fatty acids (alk-12, alk-14 and alk-16) functioned as efficient chemical reporters 
of protein fatty-acylation and exhibited chain length-dependent protein labeling (Figure 
7a).  The similar profiles of fatty-acylated proteins visualized by azido- or alkynyl-fatty 
acid metabolic labeling and CuAAC in-gel fluorescence analysis reinforce the concept 
that the small azide and alkyne chemical reporters afford efficient tools to visualize 
protein fatty-acylation in cells (Figure 7a).  Comparative analysis of fatty-acylated 
proteins visualized by in-gel fluorescence scanning demonstrated that alkynyl-fatty acid 
chemical reporters, in combination with the azido-rhodamine (az-rho) detection tag, 
improve the sensitivity of bioorthogonal labeling compared to the reverse CuAAC 
orientation owing to lower background signal (Figure 6b,7a).  These observations are 
consistent with other studies using alkyne- or azide-functionalized chemical probes[52, 
56].
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2.2.2 Specificity and generality of fatty-acylated protein labeling with chemical 
reporters 
Having established robust fluorescence detection of proteins metabolically labeled 
with alkynyl-fatty acid chemical reporters, we determined their kinetics and specificity of 
labeling fatty-acylated proteins in cells.  Time- and dose-dependent analyses of metabolic 
labeling with the alkynyl-fatty acids revealed that CuAAC and in-gel fluorescence 
imaging protocol required shorter labeling time (minutes) and lower concentrations of 
fatty acid chemical reporters to robustly detect fatty-acylated proteins compared to 
streptavidin blotting[22] (Figure 8a,b).  Competition of alkynyl-fatty acid protein labeling 
(alk-12, alk-14 and alk-16) with naturally occurring fatty acids revealed that alk-12 
protein labeling is preferentially blocked by myristic acid, whereas alk-14 and alk-16 
protein labeling is most effectively reduced by palmitic acid (Figure 9a,b).  Inhibition of 
protein synthesis with cycloheximide (CHX) abrogated the metabolic labeling of several 
prominent polypeptides by alk-12 (Figure 10a).  Most proteins targeted by alk-12, alk-14 
and alk-16 were resistant to CHX treatment, however, suggesting fatty-acylation of these 
protein substrates occurs posttranslationally.  Coincubation of the alkynyl-fatty acids with 
2-hydroxymyristic acid (HMA), a reported N-myristoylation inhibitor[57], selectively 
blocked alk-12 protein labeling compared to alk-14 and alk-16 (Figure 10b).  In contrast, 
addition of 2-bromopalmitic acid (2BP), a nonspecific S-palmitoylation inhibitor[58], at 
concentrations that did not induce cell death reduced protein labeling with alk-12, alk-14 
and alk-16 (Figure 10c).  To differentiate between N-myristoylated and S-acylated 
proteins, az-rho-modified alkynyl-fatty acid-labeled cell lysates were subjected to in-gel 
treatment with hydroxylamine (NH2OH)[59], which preferentially cleaves thioesters at 
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neutral pH.  The fluorescent signals of alkynyl-fatty acid-labeled proteins were reduced 
after in-gel exposure to NH2OH; however, the CHX-sensitive proteins labeled by alk-12 
were resistant to NH2OH cleavage (Figure 7b).  These experiments suggest that alk-12 
cotranslationally targets N-myristoylated proteins (CHX-sensitive and NH2OH-resistant) 
as well as S-acylated proteins (CHX-resistant and NH2OH-sensitive), whereas alk-16 
preferentially labels S-acylated proteins in cell lysates.  Protein labeling with alk-14 
appears to represent a combination of alk-12 and alk-16 labeling, which is consistent with 
previous metabolic labeling experiments using az-14, an azido-fatty acid analogue 
bearing 14-carbons[45]. 
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We further evaluated the efficiency and specificity of our chemical reporters in 
the detection of different classes of fatty-acylated proteins: N-myristoylated and S-
palmitoylated – Lck[60] and Fyn[61], S-palmitoylated only - Linker for Activation of T 
Cells (LAT)[62], and S-palmitoylated and S-prenylated – Ras[63] (Figure 11a).  For these 
studies, Jurkat cells were metabolically labeled with azido- (az-12, az-15) or alkynyl- 
(alk-12, alk-16) fatty acids.  Proteins of interest were immunoprecipitated from cell 
lysates, subjected to CuAAC with biotinylated (alk-biotin, az-biotin) or fluorescent (alk-
rho, az-rho) detection tags prior to visualization by streptavidin blot (Figure 11b) or in-
gel fluorescence scanning (Figure 11c), respectively.  As with cell lysates, in-gel 
fluorescence detection of the immunopurified fatty-acylated proteins (Lck, LAT and Ras) 
was markedly improved compared to streptavidin blotting and alkynyl-fatty acids/azido-
rhodamine afforded the optimal signal-to-noise for fluorescent detection (Figure 11b,c).  
For example, S-acylation of LAT was observed with myristic acid analogues (az-12, alk-
12) and nearly undetectable using palmitic acid analogues (az-15, alk-16) by streptavidin 
blotting (Figure 11b, top panels), but was robustly visualized by in-gel fluorescence 
scanning (Figure 11c, top panels).  Similar observations were obtained with Lck and Ras 
(Figure 11b,c, middle and bottom panels).  Although it is unclear why the detection of S-
acylated proteins is more efficient with myristic acid analogues (az-12, alk-12) compared 
to palmitic acid analogues (az-15, alk-16) by streptavidin blotting, direct in-gel 
fluorescence detection affords more consistent, reproducible and specific visualization of 
fatty-acylated proteins that avoids any variability associated with immunoblotting of 
hydrophobic lipidated proteins (Figure 11b,c). 
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Fatty acid chemical reporters combined with fluorescence detection enables 
specific detection of N-myristoylated and S-palmitoylated proteins.  Fatty-acylation of 
Lck, a N-myristoylated and S-palmitoylated protein, was readily observed with myristic 
acid (az-12 and alk-12) and palmitic acid (az-15, alk-16) chemical reporters, whereas 
LAT and Ras, S-palmitoylated proteins without N-terminal Gly residues, were more 
prominently labeled with palmitic acid chemical reporters (az-15, alk-16) (Figure 11c).  
The low levels of LAT and Ras labeling with az-12 and alk-12 is consistent with our 
experiments with cell lysates (Figure 7c,d), which further demonstrates that myristic acid 
analogues can be incorporated onto S-acylated proteins, albeit less efficiently than longer 
chain fatty acids.  These observations are not unexpected, as S-acylation is known to 
involve a heterogeneous composition of fatty acids[64].  In-gel NH2OH treatment of 
alkynyl-fatty acid labeled Lck and LAT reduced the fluorescent signal derived from alk-
16 on both proteins, but did not alter the alk-12 labeling of Lck (Figure 12a).  We also 
analyzed the specificity of our fatty acid chemical reporters with wild-type and mutant 
constructs of p59 Fyn[61], a well-characterized N-myristoylated and S-palmitoylated Src-
family kinase, by overexpression in HeLa cells, metabolic labeling and 
immunoprecipitation (Figure 12b).  Fatty-acylation of wild-type Fyn is readily detected 
with alk-12 and alk-16 labeling, whereas the N-myristoylation G2A mutant exhibited 
significantly reduced alk-12 labeling and was undetectable with alk-16 (Figure 12b).  The 
dual S-palmitoylation-deficient C3,6S mutant Fyn was efficiently labeled with alk-12 and 
not with alk-16 (Figure 12b).  These results are quantitatively identical to previously 
described experiments using radiolabeled fatty acids, which also demonstrated residual 
labeling of G2A mutant Fyn with a 125I-myristic acid analog and no labeling with 125I-
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palmitic acid analogue[61, 65].  Our experiments therefore also support the model that N-
myristoylation precedes S-palmitoylation and highlight the possibility of fatty-acylation 
at N-terminal alanine residues.  In contrast to LAT, Lck, Ras and Fyn, no alkynyl-fatty 
acid labeling was observed for p53, a prominent acetylated protein for which fatty-
acylation has not been reported[66], when analyzed in parallel with LAT, Lck and Ras 
(Figure 12c,d).  Collectively, our experiments with cell lysates and specific proteins 
demonstrate that alk-12 and alk-14 label N-myristoylated and S-acylated proteins, 
whereas longer-chain fatty acid chemical reporters such as alk-16 preferentially target S-
acylated proteins. 
The generality of our method was evaluated by labeling different mammalian cell 
types (HeLa, 3T3, DC2.4, Jurkat and primary splenocytes) with alkynyl-fatty acids (alk-
12 or alk-16).  This comparative analysis revealed remarkably diverse profiles of fatty-
acylated proteins amongst different cell types (Figure 13a,b).  While some fatty-acylated 
polypeptide bands are common among the different cell types, distinct N-myristoylation 
and S-palmitoylation patterns are readily apparent.  Indeed, the complete repertoire of 
fatty-acylated proteins varies dramatically between epithelial cell lines (HeLa and NIH 
3T3 fibroblasts), a monocyte-derived cell line (DC2.4), T cells (Jurkat) and splenocytes 
(Figure 13a,b).  These experiments highlight the utility of our fatty acid chemical 
reporters and improved detection conditions, which demonstrate unique profiles of fatty-
acylated proteins in discrete cell types and primary tissues that undoubtedly contribute to 
specific cellular properties. 
  
F
(
1
igure 13: Profil
HeLa, 3T3, DC2
6).  Comparable
e of fatty-acylat
.4 or Jurkat T cel
 levels of protein
ed proteomes in 
ls) or (b) splenoc
 loading were dem
different cell lin
ytes metabolical
onstrated by Co
32 
es and mouse tis
ly labeled with D
omassie staining
sues.  Fatty-acyl
MSO (-) or alky
 of the gels. 
ated proteins fro
nyl-fatty acids (2
m (a) mammali
0 M alk-12 or 2
 
an cell lines 
00 M alk-
 33 
 
The visualization of fatty-acylated proteins from living animals would afford new 
opportunities to address protein lipidation in physiology and disease.  To explore the 
utility of our fatty acid chemical reporters in vivo, mice were intraperitoneally injected 
with alkynyl-fatty acids (alk-12 or alk-16) and analyzed for protein fatty-acylation in 
various tissues.  Following one hour of metabolic labeling with our alkynyl-fatty acids in 
vivo, protein fatty-acylation could be visualized in cell lysates prepared from splenocyte, 
liver and kidney (Figure 14a).  In particular, in vivo labeling with alk-12 afforded a 
discrete profile of fatty-acylated proteins from splenocytes similar to ex vivo labeling 
(Figure 13b,14a).  While the profile of S-palmitoylated proteins with alk-16 was not as 
prevalent as ex vivo labeling experiments, specific fatty-acylated proteins are clearly 
detected from tissues (Figure 14a).  The analysis of protein fatty-acylation profiles at 
different times after in vivo administration in splenocyte and liver lysates revealed that 
the labeling of fatty-acylated proteins decreases over time (Figure 14b).  These 
experiments suggest that protein fatty-acylation is quite dynamic in vivo.  Nonetheless, 
these in vivo labeling experiments demonstrate that alkynyl-fatty acid chemical reporters 
can function in living animals and enable the specific detection of fatty-acylated proteins 
in primary tissues.  It should also be noted that our fatty acid chemical reporters were 
well tolerated by the mice, as no overt toxicity was observed following in vivo 
administration, even after several days. 
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2.3 Application of fatty acid chemical reporters 
The utility of alkynyl-fatty acids for the detection and analysis of fatty-acylated 
proteins in cells was demonstrated through several collaborations.  The large-scale 
proteomic analysis of mammalian proteins targeted by alkynyl-fatty acid chemical 
reporters in total cell lysates from fully solubilized Jurkat T cells identified known fatty-
acylated proteins and many new candidates, including nuclear proteins and in particular 
histone H3 variants[67].  This collaboration with Dr John Wilson revealed that histones 
H3.1, H3.2, and H3.3 are modified with fatty acid chemical reporters and identified the 
conserved cysteine 110 as a new site of S-acylation on histone H3.2.  This newly 
discovered modification of histone H3 could have implications for nuclear organization 
and chromatin regulation.  Proteomic studies with Dr Jacob Yount also identified over 
150 lipid-modified proteins with diverse cellular functions, including innate immunity, by 
large-scale profiling of palmitoylated proteins with alkynyl-fatty acid alk-16 in a 
dendritic cell line[10].  The study revealed that S-palmitoylation of interferon-induced 
transmembrane protein 3 (IFITM3) on membrane-proximal cysteines controls its 
clustering in membrane compartments and its antiviral activity against influenza virus.  
The sites of S-palmitoylation are highly conserved among the IFITM family of proteins 
in vertebrates, which suggests that S-palmitoylation of these immune effectors may be an 
ancient post-translational modification that is crucial for host resistance to viral 
infections. 
Metabolic labeling of bacteria with fatty acid chemical reporters by Kavita 
Rangan allowed rapid profiling of largely uncharacterized bacterial lipoproteins[9].  We 
identified many candidate lipoproteins in Escherichia coli and detected a novel fatty-
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acylation modification on YjgF.  Dr Stuart Hicks in the Galan Laboratory at Yale School 
of Medicine also showed that S-palmitoylation of a conserved cysteine residue within the 
N-terminal domains of Salmonella typhimurium secreted effectors SspH2 and SseI 
localizes them to the plasma membrane of host cells and that effector protein lipidation is 
critical for effector function[12]. 
Using these fatty acid reporters, Dr Mingzi Zhang and Dr Lun Kelvin Tsou 
described a tandem labeling and detection method to simultaneously monitor dynamic S-
palmitoylation and protein turnover[68].  By combining S-acylation (alk-16) and 
cotranslational (az-12) fatty acid chemical reporters with orthogonal azide/alkyne 
fluorophores, dual pulse-chase analysis of Lck revealed accelerated palmitate cycling 
upon T-cell activation.  Pharmacological perturbation of Lck palmitate turnover suggests 
yet uncharacterized serine hydrolases contribute to dynamic S-acylation in cells.  Dr 
Stuart Hicks in Machamer Laboratory (Johns Hopkins University) also observed 
differential dynamics of palmitoylation sites in a G protein-coupled receptor (GPCR), the 
cytoplasmic tail of β1-adrenergic receptor[69].  Palmitoylation at the proximal site, a 
consensus for GPCRs, is remarkably stable, while palmitoylation at the distal site is 
rapidly turned over.  These sites are modified in different cellular compartments, and the 
distal palmitoylation site contributes to efficient internalization of the receptor following 
agonist stimulation.  Our results have important implications for function and regulation 
of the clinically important β1-adrenergic receptor. 
The proteomic analysis of fatty-acylated proteins using alkynyl-fatty acid 
chemical reporters has revealed a greater diversity of lipid-modified proteins in 
mammalian and bacterial cells than previously appreciated and identified novel post-
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translational fatty-acylation of proteins.  Detection of S-palmitoylation of IFITM3, YjgF, 
SspH2, SseI and β1-adrenergic receptor are important for elucidating their mechanism of 
action and for the design of therapeutics.  Furthermore, tandem imaging method using 
fatty-acid chemical reporters allows the investigation of dynamic palmitoylation-
dependent regulation of protein function.  The sensitivity and efficiency of alkynyl-fatty 
acid chemical reporter and CuAAC ligation should facilitate the functional 
characterization of cellular factors and drugs that modulate protein S-acylation in the 
future.  
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CHAPTER III. Chemical reporters of protein prenylation 
3.1 Alkynyl-isoprenoids synthesis 
 We designed alkynyl-isoprenol chemical reporters based on farnesol, since 
corresponding chemical reporters are substrates of FTase and GGTase-I in vitro[70].  We 
utilized a synthetic scheme that would allow access to a diverse panel of alkynyl-farnesol 
derivatives (alk-FOH, alk-FOH-2 and alk-FOH-3), as well as an azide analog (az-
FOH) for comparison purposes, from a common intermediate (Figure 15).  After THP 
protection, commercially available farnesol can be selectively oxidized at the terminal 
allylic position[71] to give functionalized farnesol derivative 4.  Allylic alcohol 4 was 
then alkylated with propargyl bromide to obtain protected alkynyl-farnesol 5, and then 
deprotected in acidic ethanol yielding alk-FOH, a precursor to previously reported 
alkynyl-farnesol diphosphate that can be incorporated onto peptide substrates by both 
FTase and GGTase-I in vitro[70].  Corey-Kim like halogenation[72] of allylic alcohol 4 
enabled access to allylic bromide intermediate 6.  CuI/K2CO3 mediated coupling with 
TMS-acetylene afforded enyne 7, which was subsequently deprotected in two steps to 
yield alk-FOH-2.  Alternatively, allyl bromide 6 was alkylated with lithiated TMS-1-
propyne to give enyne 8, which after deprotection afforded alk-FOH-3 that is one 
methylene unit longer than alk-FOH-2.  Az-FOH was also obtained in a similar manner 
by displacement of the bromide 6 with sodium azide to obtain 9, followed by THP 
deprotection (Figure 15). 
  
Figure 15: Synthesis of prenylation reporters. 
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3.2 Alkynyl-isoprenoids characterization 
3.2.1 Comparative analysis of bioorthogonal labeling methods 
With all three alkynyl-farnesol reporters in hand, we assayed whether these 
compounds would be metabolically incorporated into mammalian cells and installed onto 
endogenous target proteins.  Jurkat T cells were incubated with alk-FOH, alk-FOH-2, 
alk-FOH-3 or az-FOH at 50 M for 4 hrs, lysed and conjugated to azido-rhodamine[7] 
(in the case of alk-FOHs) or alk-rhodamine[7] (for az-FOH) via CuAAC, separated by 
SDS-PAGE and analyzed by in-gel fluorescence scanning (Figure 16a).  The banding 
pattern of proteins with the alk-FOH probes was similar to az-FOH labeling, suggesting 
that all three alk-FOHs were incorporated onto farnesylated proteins.  Labeling was 
stronger with alk-FOH and alk-FOH-3 with markedly stronger signal in the 20-25 kDa 
molecular weight region known to comprise small GTPases.  We also determined the 
effect of HMG-CoA reductase inhibitors (lovastatin) on the incorporation efficiency and 
detection sensitivity in comparison to az-FOH.  Robust signal over the background was 
obtained without HMG-CoA reductase inhibitors using alkynyl-FOHs, whereas only few 
specific bands could be detected with previously reported az-FOH[73].  Optimal 
concentration for alk-FOH was 50 M, as judged by labeling of Jurkat cell lysates 
(Figure 16b).  Addition of alk-FOH at 100 M resulted in cellular toxicity that was not 
observed at lower concentrations (data not shown). 
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3.2.2 Specificity and generality of prenylated protein labeling with chemical 
reporters 
To determine whether the alkynyl-farnesol reporters indeed targeted S-prenylated 
proteins, we evaluated the labeling of known farnesylated protein (H-Ras) and two 
different classes of geranylgeranylated proteins (RhoA and Rab7).  All three reporters 
successfully visualized Ras farnesylation upon lovastatin treatment (Figure 17a).  
Nonetheless, alk-FOH and alk-FOH-3 afforded better detection of Ras farnesylation than 
alk-FOH-2 and az-FOH, even at endogenous levels (without lovastatin pre-treatment, 
Figure 17a).  We focused on alk-FOH, as this chemical reporter can be readily 
synthesized and stable compared to other alkynyl-farnesol reporters.  Alk-FOH was then 
assayed with a known substrate protein of each prenyltransferase in HeLa cells 
transiently expressing Ras for FTase, RhoA for GGTase-I and Rab7 for GGTase-II.  All 
three proteins were labeled by alk-FOH (Figure 17b).  Furthermore, selective depletion of 
the Ras signal was observed when incubating the cells with a FTase inhibitor (FTI-277, 
10 M), and selective diminution of the RhoA signal was observed with a GGTase-I 
inhibitor (GGTI-2133, 10 M) while the signal was unaffected in the case of Rab7 
(Figure 17b).  This demonstrates that alk-FOH can be incorporated as a substrate for all 
three prenyltransferases in cells and hence a useful tool to detect protein S-prenylation.  
Alk-FOH was also incorporated by a variety of other cell types (fibroblasts: HeLa, 3T3; 
leukocytes: Jurkat, DC2.4 and RAW264.7) demonstrating the generality of this chemical 
reporter (Figure 17c).  Each cell line exhibited a different banding pattern, highlighting 
the heterogeneity of S-prenylated proteins among unique cell types. 
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3.2.3 Detection of prenylated bacterial effector 
 Having demonstrated the efficient detection of S-prenylated proteins in 
mammalian cells with alk-FOH, I evaluated S-prenylation of Salmonella type III 
secretion system effector SifA[8].  The bacterial protein effector SifA is translocated into 
the host cytoplasm after bacterial infection and localizes to membranes of the 
Salmonella-containing vacuoles (SCVs)[74].  SifA induces the formation of tubular 
membrane extensions of the SCV termed Salmonella-induced filaments (Sifs)[74], which 
are necessary for maintaining the integrity of the SCV and Salmonella virulence[75].  
The C-terminal motif of SifA (331CLCCFL336) contains an unusual prenylation motif that 
can be interpreted either as a CaaX motif and/or a Rab protein motif (CCXX) and S. 
typhimurium lacking this SifA C-terminal hexapeptide exhibited a significant defect in 
bacterial replication[76].  Although the S-prenylation prediction suite (PrePS)[77] does 
not recognize SifA as a substrate for any prenyltransferase, SifA was labeled specifically 
at cysteine 333 by [3H]mevalonic acid in rabbit reticulocyte lysate in vitro[36].  These 
data suggest that SifA is S-prenylated by the host cell machinery for recruitment to the 
SCV membrane[36, 76], although SifA S-prenylation could not be detected by 
[3H]mevalonic acid labeling in cells.  The precise roles of SifA S-palmitoylation and S-
prenylation during Salmonella infection are unclear, as single point mutations of putative 
lipidation sites do not recapitulate the defect in Salmonella replication observed with the 
SifA mutant lacking the entire C-terminal hexapeptide[36, 76]. 
To provide more insight into SifA S-prenylation in cells, N-terminally HA-tagged 
SifA (HA-SifA) was transiently expressed in HeLa cells and metabolically labeled with 
alk-FOH.  HA-SifA was then immunopurified, reacted with az-rho via CuAAC and 
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analyzed by in-gel fluorescence scanning.  Alk-FOH afforded robust visualization of 
SifA prenylation in cells for the first time (Figure 18a).  As opposed to previous in vitro 
radioactive labeling studies[36], we observed residual cellular HA-SifA prenylation 
(~40%) in the presence of GGTase-I inhibitors (GGTI-298 or GGTI-2133, 10 M).  
Furthermore, inhibition of FTase (with FTI-277, 10 M) or dual inhibition of FTase and 
GGTase-I in cells retained residual SifA prenylation (~20% and ~50%, respectively) 
(Figure 18a), suggesting that SifA is a substrate for more than GGTase-I.  Single 
mutations of SifA C-terminal cysteines to serines (HA-SifAC333S, HA-SifAC334S) each 
retained about 30% of prenylation compared to wild-type, while dual mutations (HA-
SifAC333,334S) or triple cysteine mutations (HA-SifAC331,333,334S) were not prenylated by 
alk-FOH in cells (Figure 18b), suggesting that SifA is dually prenylated at cysteines 333 
and 334.  These results are in contrast with SifA in vitro radioactive labeling studies, 
where a single mutation (HA-SifAC333S) was sufficient to deplete SifA prenylation[36]. 
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 Collaboration with the Roy laboratory (Yale School of Medicine) also enabled the 
identification of prenylated Legionella pneumophila effector proteins[11].  Upon 
phagocytosis, Legionella delays endocytic maturation of the vacuole in which it 
resides[78-79] and promotes the recruitment and fusion of early secretory vesicles to the 
vacuolar membrane[80-82].  Successful establishment of a vacuole that supports bacterial 
replication is mediated by the collective action of bacterial effector proteins[83-85] that 
are translocated into the host cytosol by Legionella via a specialized type IV secretion 
system called Dot/Icm[86-87].  The translocated effectors subvert different host 
processes to conduct vacuole remodeling[88].  Although the functions of most of the over 
200 Legionella effectors identified so far remain largely unknown, many of the bacterial 
effectors have been found to modulate host functions at the cytosolic face of host 
membrane compartments[89-91].  Many of these effectors are incorporated into the 
pathogen-containing vacuolar membrane by unknown mechanisms and recent genomic 
analyses of Legionella revealed effectors bearing a C-terminal CaaX motif[11, 38], 
suggesting protein prenylation may target effectors to membrane compartments. 
 To further define the mechanisms used for membrane localization of Legionella 
effector proteins, we have been investigating the role protein prenylation by host 
enzymes might play in this process.  Individual polypeptides from the proteomes of L. 
pneumophila strain Philadelphia, strain Paris, strain Lens, and strain Corby were 
analyzed for the presence of a cysteine residue at the fourth position from the C terminus 
and analyzed using the prenylation prediction program PrePS[77] to identify proteins 
having an appropriate CaaX motif.  Ten Legionella proteins containing high confidence 
putative CaaX motif were identified and they lacked homology outside of the CaaX 
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motif, suggesting that these proteins encode different functions (Figure 19a).  They were 
translocated into the cytosol of eukaryotic cells by the Dot/Icm system, and they 
associated to membranes in a CaaX-dependent manner.  Alk-FOH labeled 293T cells 
expressing GFP-fusions of Legionella CaaX effectors, immunoprecipitation and CuAAC 
fluorescent tagging revealed incorporation of alk-FOH, and demonstrated that these 
proteins are prenylated at the Cys residue of the CaaX motif unlike their CS mutants 
(Figure 19b).  To distinguish which prenyltransferases mediate lipidation of the 
individual proteins, the activity of FTase or GGTase I was perturbed using different 
pharmacological inhibitors.  Lpg2144, Lpl2806, and Lpl2477 were found to be FTase 
substrates, whereas Lpg0254, Lpg1976, Lpg2375, Lpg2525, Lpl1863, and Lpg2541 were 
substrates recognized by both FTase and GGTase I (Figure 19b).  Lpp1863 failed to 
incorporate alk-FOH, suggesting that Lpp1863 contains a non-functional CaaX motif.  
These data provide biochemical evidence that Legionella effectors are lipidated and 
specific substrates of the eukaryotic prenylation machinery.  We demonstrated that 
subversion of the eukaryotic prenylation machinery is a mechanism that is used for the 
targeting of bacterial effectors to host membrane-bound compartments. 
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Figure 19 (next page): Detection of prenylation of Legionella bacterial effectors prenylation.  (a) 
Putative domains encoded within Legionella CaaX effectors.  ANK, ankyrin repeat domain; 
RCC1, regulator of chromosome condensation domain.  (b) HeLa cells transiently expressing 
Legionella effector-GFP fusion proteins and isogenic CS mutants in the presence/absence of FTI-
227 (10 μM) or GGTI-2133 (10 μM) for 1 hour before supplementing the media with prenylation 
reporter alk-FOH (50 μM, 4 hours).  Immunopurified proteins labeled with alk-FOH were 
conjugated via CuAAC to azido-rhodamine (az-rho), followed by separation by SDS-PAGE and 
fluorescence detection or immunoblotting as a loading control.  Fluorescence was quantified by 
mean fluorescence intensity adjusted for loading and normalized for background (0) and strongest 
signal (1). 
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3.3 Proteomic identification of prenylated proteins 
Although bioinformatics predict hundreds of prenylated proteins in eukaryotes 
based on CaaX or C(X)C motifs of known substrates[77], only a small fraction has been 
characterized biochemically and experimentally validated.  The application of azido- or 
biotin-isoprenoid chemical reporters have enabled the enrichment and identification of 
farnesylated[44] or geranylgeranylated protein subsets[73, 92], but the general proteomic 
coverage of prenylated proteins has been limited.  Having demonstrated that alkynyl-
farnesol (alk-FOH) enables more efficient labeling and detection of prenylated proteins in 
mammalian cells compared to their azide-counterparts using CuAAC[8, 93], I envisioned 
the application of this lipid chemical reporter for the enrichment and identification of 
prenylated proteins using improved bioorthogonal proteomic methods.  We recently 
developed an azide-biotin tag for CuAAC that incorporates an azobenzene moiety that 
can be selectively cleaved by reduction with sodium dithionite, allowing selective elution 
of streptavidin bound proteins under conditions compatible with mass spectrometry 
analysis[94-95]. 
3.3.1 Synthesis of cleavable linker azido-azo-biotin for proteomic analysis 
 Tyramine (10) was converted to the azido-phenol (11) via diazo-transfer from 
triflyl azide[96] in good yield (Figure 20).  The azobenzene (12) was then readily 
accessible through diazotization of 4-aminobenzoic acid and reaction with azido-phenol 
(11).  Subsequent coupling of the corresponding N-hydroxysuccinimide-ester (13) with 
pegylated-biotin-amine (from Figure 5b) afforded az-azo-biotin (Figure 20). 
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3.3.2 Proteomic analysis of prenylated proteins in RAW264.7 macrophages 
To identify lipid-modified proteins involved in immune responses to microbial 
infections, we performed a large-scale profiling of prenylated proteins in the mouse 
macrophage line RAW264.7[97] using the isoprenoid chemical reporter alkynyl-farnesol 
(alk-FOH)[8] and CuAAC.  Alk-FOH targets the substrates of all three prenyltransferases 
in cells: CaaX S-farnesylated and S-geranylgeranylated proteins, as well as C(X)C 
RabGTPases[8].  In-gel fluorescence profiling of RAW264.7 cell lysates reacted with an 
azide-functionalized fluorophore, azido-rhodamine (az-rho)[7], demonstrated that a 
diverse repertoire of proteins are metabolically labeled by alk-FOH (Figure 21a).  Cell 
lysates were then reacted with a cleavable affinity tag (az-azo-biotin)[94] for enrichment 
of alk-FOH labeled proteins with streptavidin beads, selective elution and gel-based 
proteomic identification by mass spectrometry.  Coomassie blue staining of proteins 
retrieved with streptavidin beads and sodium dithionite (Na2S2O4) elution demonstrates 
the specificity of alk-FOH and CuAAC labeling methods (Figure 21b).  Proteins 
identified in three independent experimental runs were compiled and categorized into 
high- and medium-confidence lists on the basis of the total number of assigned spectra 
and the fold-increase above control samples that were not labeled with alk-FOH.  For this 
analysis, we selectively identified 114 proteins by alk-FOH labeling as compared to 
control samples, with 52 and 62 proteins assigned to high- and medium-confidence lists, 
respectively (Figure 21c, Tables 3 and 4).  Of the high-confidence list, 35 percent (23 + 
12) of hits bear a carboxyl-terminal CaaX or C(X)C motif, respectively (Table 3).  Of 
these putative prenylated proteins, 61 percent of high- and medium-confidence hits have 
been reported in previous labeling and enrichment studies with biotin, azide or alkyne 
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chemical reporters in other cell types (Tables 3 and 4).  These proteins include K-Ras, 
Cdc42, Lamin-B1, DnaJA2, Rap2C and Rab proteins (Figure 21c, Tables 3 and 4).  In 
addition, RhoA, Ptp4A, Ykt6, Rac2, Brox and RhoG, which have predicted prenylation 
sites, were recovered in our alk-FOH proteomic dataset (Figure 21c, Tables 3 and 4).  In 
comparison with previous proteomic studies that targeted subsets of S-prenylated 
proteins[44, 73, 92-93], our proteomic analysis of alk-FOH labeled proteins recovered 
both farnesylated and geranylgeranylated proteins as well as many other candidate 
isoprenoid-modified proteins (Tables 3 and 4).  Notably, we identified the long-isoform 
of zinc-finger antiviral protein (ZAPL) as a high-confidence hit, which was not 
previously annotated as a prenylated protein. 
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Table 3 (next page): Proteins selectively identified with high confidence in alk-FOH samples by mass spectrometry.  Data was categorized as 
high confidence if the sum of assigned spectra was at least 10 fold greater for alk-FOH samples than the sum of DMSO samples (column labeled 
α), or if the sum of assigned spectra was at least 10 if no spectra was assigned in DMSO samples (column labeled Δ).  Data was compared to other 
chemical reporter based prenylome proteomics data sets from the Zhao[44], Tamanoi[73], Alexandrov[92] and Distefano[93] groups.  Proteins 
bearing a C-terminal CaaX or C(X)C motif were shaded green, and the motif sequence was displayed, along with the prenyltransferase preference 
for the substrate according to UniProtKB database and PrePS prenylation prediction.  CaaX proteins were shaded red if they had not been 
previously reported as prenylated in UniProtKB. 
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Table 3: Proteins selectively identified with high confidence in alk-FOH samples by mass spectrometry. 
    lovastatin +   
      1 2 3 SUM Other groups CaaX/Rab Swiss-prot PrePS prediction
# Gene Description Accession # - + - + - +   Alexandrov Distefano Zhao Tamanoi motif annotation FTase GGTase-I GGTase-II 
1 Pfkp Isoform 1 of 6-phosphofructokinase type C IPI00124444 0 52 0 48 15 217 302 21   
2 Aldh9a1 4-trimethylaminobutyraldehyde dehydrogenase IPI00124372 0 18 0 26 0 113 157 -   
3 Atp2a2 Isoform SERCA2B of Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 IPI00338964 0 46 0 41 4 57 140 36   
4 Acaa1a 3-ketoacyl-CoA thiolase A, peroxisomal IPI00121833 0 24 0 34 9 79 128 15   
5 Vdac2 Voltage-dependent anion-selective channel protein 2 IPI00122547 1 17 2 17 4 67 94 14   
6 Hsd17b4 Peroxisomal multifunctional enzyme type 2 IPI00331628 0 11 0 13 0 69 93 -   
7 Rhoa  Transforming protein RhoA IPI00315100 0 24 1 14 2 41 76 26   CLIL GGTase-I ++ +++
8 Kras Isoform 2B of GTPase KRas IPI00134941 0 10 0 8 0 55 73 -   X CVIM FTase +++ +++
9 Slc25a5 ADP/ATP translocase 2 IPI00127841 0 6 1 7 7 52 57 8   
10 Cdc42  Isoform 2 of Cell division control protein 42 homolog IPI00113849 0 3 0 1 0 49 53 -   X CVLL GGTase-I ++ +++
11 Ptges2 prostaglandin E synthase 2 IPI00947625 0 18 0 17 0 11 46 -   
12 Hmox2 Heme oxygenase 2 IPI00309322 0 13 0 12 0 17 42 -   
13 Lmnb1  Lamin-B1 IPI00230394 1 21 0 17 0 0 37 38   X X CAIM FTase +++ +++
14 Eprs Bifunctional aminoacyl-tRNA synthetase IPI00339916 (+1) 1 11 0 12 1 15 36 19   
15 Rab10 Ras-related protein Rab-10 IPI00130118 0 4 1 5 0 23 31 32 X SKCC GGTase-II +++
16 Hsd17b12 Isoform 1 of Estradiol 17-beta-dehydrogenase 12 IPI00119219 0 0 0 2 2 29 29 16   
17 Dnaja2 DnaJ homolog subfamily A member 2 IPI00136251 0 7 0 5 1 15 26 27   X CAHQ FTase
18 Mybbp1a Myb-binding protein 1A IPI00331361 2 13 0 14 0 0 25 14   
19 Rap2c  Ras-related protein Rap-2c IPI00466588 0 6 0 2 0 16 24 -   X X CVVQ GGTase-I ++
20 Rab31  ras-related protein Rab-31 IPI00222632 0 5 0 3 0 13 21 - X RRCC GGTase-II +++
21 Zc3hav1 Zinc finger CCCH-type antiviral protein 1  IPI00136572 0 3 0 6 0 10 19 -   CIIS +
22 Soat1  Sterol O-acyltransferase 1 IPI00278153 (+1) 0 2 0 3 0 14 19 -   
23 Pfkl 6-phosphofructokinase, liver type IPI00387312 0 3 0 0 2 18 19 11   
24 Ptp4a2 Protein tyrosine phosphatase type IVA 2 IPI00116529 0 2 0 2 0 14 18 -   CCVQ FTase +
25 Pcbp1 Poly(rC)-binding protein 1 IPI00128904 0 3 0 7 1 8 17 18   
26 Tmem38b Trimeric intracellular cation channel type B IPI00119084 0 9 0 5 0 3 17 -   
27 Rtn3  Isoform 1 of Reticulon-3 IPI00470981 (+2) 0 7 0 6 2 6 17 10   
28 Cyb5b Cytochrome b5 type B IPI00315794 0 5 1 5 0 7 16 17   
29 Atp5h ATP synthase subunit d, mitochondrial IPI00230507 (+1) 0 8 1 9 1 1 16 9   
30 Ykt6  Synaptobrevin homolog YKT6 IPI00453771 0 5 0 1 0 9 15 -   CAIM FTase ++ +++
31 Rab1  Ras-related protein Rab-1A IPI00114560 (+1) 0 6 0 4 0 4 14 - X X GGCC GGTase-II +++
32 Rab18 Ras-related protein Rab-18 IPI00116770 0 2 0 2 0 10 14 - X X CSVL GGTase-I + ++ +++
33 Mtch2 Mitochondrial carrier homolog 2 IPI00132039 0 1 0 2 1 11 13 14   
34 Reep5  receptor expression-enhancing protein 5 IPI00315463 0 3 0 5 0 5 13 -   
35 Prdx6  Peroxiredoxin-6 IPI00555059 (+1) 0 6 0 3 0 4 13 -   
36 Slc25a3 Phosphate carrier protein, mitochondrial IPI00124771 (+1) 0 0 0 2 1 11 12 13   
37 Rab-7 Ras-related protein Rab-7a IPI00408892 0 4 0 2 1 7 12 13 X X X SCSC GGTase-II +++
38 Fads2 Fatty acid desaturase 2 IPI00129362 0 2 0 4 0 6 12 -   
39 Hmha1 Isoform 1 of Minor histocompatibility protein HA-1 IPI00830876 0 4 0 5 0 3 12 -   
40 Slc3a2 4F2 cell-surface antigen heavy chain IPI00114641 (+1) 0 2 0 1 1 9 11 12   
41 Eif4g1 eukaryotic translation initiation factor 4, gamma 1  IPI00858249 0 4 0 4 0 3 11 -   
42 Fxyd5  FXYD domain-containing ion transport regulator 5 IPI00129933 0 3 0 2 0 6 11 -   
43 Ptp4a1 Protein tyrosine phosphatase type IVA 1 IPI00133490 0 3 0 0 0 8 11 -   CCIQ FTase +++
44 Vdac3 Voltage-dependent anion-selective channel protein 3 IPI00122548 0 0 0 1 1 10 10 11   
45 Fcer1g High affinity immunoglobulin epsilon receptor subunit gamma IPI00119293 1 0 0 1 0 10 10 11   
46 Tmed10 Isoform 1 of Transmembrane emp24 domain-containing protein 10 IPI00466570 0 4 0 3 1 4 10 11   
47 Nrp2 neuropilin-2 isoform 3 precursor IPI00755777 0 0 0 0 0 10 10 -   CCSEA
48 mt-Co2  Cytochrome c oxidase subunit 2 IPI00131176 0 2 0 3 0 5 10 -   
49 Serbp1 Isoform 1 of Plasminogen activator inhibitor 1 RNA-binding protein IPI00471475 (+3) 0 4 0 6 0 0 10 -   
50 Rab5c Ras-related protein Rab-5C IPI00224518 (+1) 0 3 0 5 0 2 10 - X X CCSN GGTase-II +++
51 Numa1 nuclear mitotic apparatus protein 1 IPI00263048 1 6 0 4 0 0 9 10   
52 Rab1b Ras-related protein Rab-1B IPI00133706 0 5 1 3 0 2 9 10 X X GGCC GGTase-II +++
57
  
 
 
 
 
 
 
 
Table 4 (next 2 pages): Proteins selectively identified with medium confidence in alk-FOH samples.  Same as Table 3 except data was medium 
confidence if the sum of assigned spectra was at least 8 fold greater for alk-FOH samples than DMSO samples or if the sum was at least 4 if no 
spectra assigned in DMSO samples. 
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Table 4: Proteins selectively identified with medium confidence in alk-FOH samples by mass spectrometry. 
    lovastatin +   
    1 2 3 SUM Other groups CaaX/Rab Swiss-prot PrePS prediction
# Gene Description Accession # - + - + - +   Alexandrov Distefano Zhao Tamanoi motif annotation FTase GGTase-I GGTase-II 
53 Nceh1  Neutral cholesterol ester hydrolase 1 IPI00403586 0 0 0 2 0 7 9 -   
54 Sf3b2 splicing factor 3b, subunit 2 IPI00349401 0 6 0 3 0 0 9 -   
55 Tmpo Isoform Beta of Lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma IPI00320399 (+3) 0 4 0 5 0 0 9 -   
56 Spcs2 Signal peptidase complex subunit 2 IPI00228236 0 4 0 3 0 2 9 -   
57 Hsdl1 Inactive hydroxysteroid dehydrogenase-like protein 1 IPI00225301 0 1 0 1 0 7 9 -   
58 Tmem173 Isoform 1 of Transmembrane protein 173 IPI00674006 (+1) 0 2 0 2 1 5 8 9   
59 Nup155 Nuclear pore complex protein Nup155 IPI00453821 (+1) 0 1 0 5 1 3 8 9   
60 Lass2 LAG1 longevity assurance homolog 2 IPI00126253 0 0 0 1 1 8 8 9   
61 Rac2  Ras-related C3 botulinum toxin substrate 2 IPI00137618 0 4 0 1 0 3 8 -   CSLL GGTase-I + ++
62 Ermp1 Isoform 1 of Endoplasmic reticulum metallopeptidase 1 IPI00407222 0 0 0 0 0 8 8 -   
63 Ipo5 Isoform 1 of Importin-5 IPI00626994 0 1 0 0 1 7 7 8   
64 Arf1 ADP-ribosylation factor 1 IPI00221613 (+1) 0 4 0 0 1 4 7 8   
65 Fmnl1 Isoform 1 of Formin-like protein 1 IPI00123377 0 1 0 2 1 5 7 8   
66 Cse1l Exportin-2 IPI00112414 1 2 0 1 0 5 7 8   
67 Rab2a Ras-related protein Rab-2A IPI00137227 0 3 0 1 1 4 7 8 X X X GGCC GGTase-II +++
68 Pdcd11 Protein RRP5 homolog IPI00551454 0 3 0 4 0 0 7 -   
69 Lrrc59 Leucine-rich repeat-containing protein 59 IPI00123281 0 2 0 1 0 4 7 -   
70 Txndc12 Thioredoxin domain-containing protein 12 IPI00133110 0 1 0 2 0 4 7 -   
71 Hmox1 Heme oxygenase 1 IPI00131577 0 0 0 1 0 6 7 -   
72 Rbm8a Isoform 2 of RNA-binding protein 8A IPI00109860 0 4 0 3 0 0 7 -   
73 Atl3  Isoform 1 of Atlastin-3 IPI00458393 (+1) 0 1 0 2 0 3 6 -   
74 Bax Apoptosis regulator BAX IPI00120684 (+1) 0 1 0 0 0 5 6 -   
75 Vat1 Synaptic vesicle membrane protein VAT-1 homolog IPI00126072 0 0 0 0 0 6 6 -   
76 U2surp U2 snRNP-associated SURP motif-containing protein 1 IPI00467507 0 2 0 4 0 0 6 -   
77 Cd44 CD44 antigen isoform c precursor IPI00223769 (+21) 0 0 0 0 0 6 6 -   
78 Stom  Erythrocyte band 7 integral membrane protein IPI00323748 0 1 0 2 0 3 6 -   
79 Arl1 ADP-ribosylation factor-like protein 1 IPI00278498 0 1 0 1 0 4 6 -   
80 Adpgk Isoform 1 of ADP-dependent glucokinase IPI00132529 (+1) 0 0 0 0 0 6 6 -   
81 Tap1 Antigen peptide transporter 1 IPI00129803 0 2 0 2 0 1 5 -   
82 Rab14 Ras-related protein Rab-14 IPI00126042 0 0 0 0 0 5 5 - X X GCGC GGTase-II +++
83 Tor1aip1 Lamina-associated polypeptide 1B IPI00762273 0 2 0 2 0 1 5 -   
84 Ugt1a7c UDP-glucuronosyltransferase 1-7C IPI00417181 0 0 0 2 0 3 5 -   
85 Got1 Aspartate aminotransferase, cytoplasmic IPI00230204 (+1) 0 0 0 1 0 4 5 -   
86 Tomm40 Mitochondrial import receptor subunit TOM40 homolog IPI00474157 0 0 0 2 0 3 5 -   
87 Slc7a5 Large neutral amino acids transporter small subunit 1 IPI00129395 0 2 0 2 0 1 5 -   
88 Prdx3 Thioredoxin-dependent peroxide reductase, mitochondrial IPI00116192 0 2 0 0 0 3 5 -   
89 Sec23b Protein transport protein Sec23B IPI00317604 0 1 0 1 0 3 5 -   
90 Ifitm3 Interferon-induced transmembrane protein 3 IPI00133243 0 0 0 0 0 5 5 -   
91 Pmpca Mitochondrial-processing peptidase subunit alpha IPI00120199 0 1 0 2 0 2 5 -   
92 Brox Isoform 1 of BRO1 domain-containing protein BROX IPI00453679 0 0 0 0 0 5 5 -   CSVS FTase ++
93 Dctn1 Isoform 1 of Dynactin subunit 1 IPI00115663 (+1) 0 1 0 1 0 2 4 -   
94 Mars Methionyl-tRNA synthetase, cytoplasmic IPI00461469 (+1) 0 1 0 2 0 1 4 -   
95 Rps3a 40S ribosomal protein S3a IPI00331345 (+2) 0 0 0 3 0 1 4 -   
96 Apex1 DNA-(apurinic or apyrimidinic site) lyase IPI00224152 0 0 0 3 0 1 4 -   
97 Acsl1 Long-chain-fatty-acid--CoA ligase 1 IPI00112549 (+2) 0 2 0 2 0 0 4 -   
98 Nup160 Isoform 1 of Nuclear pore complex protein Nup160 IPI00129535 0 2 0 1 0 1 4 -   
99 Eftud2 116 kDa U5 small nuclear ribonucleoprotein component isoform b IPI00649950 0 1 0 3 0 0 4 -   
100 Nomo1 Nodal modulator 1 IPI00222429 0 3 0 1 0 0 4 -   
101 Eif3a Eukaryotic translation initiation factor 3 subunit A IPI00129276 (+1) 0 1 0 0 0 3 4 -   
102 Nesprin-3 Isoform 1 of Nesprin-3 IPI00457960 0 0 0 0 0 4 4 -   
103 Mthfd1 C-1-tetrahydrofolate synthase, cytoplasmic IPI00953783 0 2 0 2 0 0 4 -   
104 Cpsf1 Cleavage and polyadenylation specificity factor subunit 1 IPI00110363 0 1 0 3 0 0 4 -   
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105 Pebp1 Phosphatidylethanolamine-binding protein 1 IPI00137730 0 1 0 1 0 2 4 -   
106 Ndufa5 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 IPI00331332 0 0 0 4 0 0 4 -   
107 Rpl21 60S ribosomal protein L21 IPI00315548 (+3) 0 2 0 0 0 2 4 -   
108 Sf3a1 Splicing factor 3A subunit 1 IPI00408796 0 3 0 1 0 0 4 -   
109 Abhd12 Monoacylglycerol lipase ABHD12 IPI00165731 0 0 0 0 0 4 4 -   
110 Gnaq Guanine nucleotide-binding protein G(q) subunit alpha IPI00228618 0 0 0 1 0 3 4 -   
111 Psmb5 Proteasome subunit beta type-5 IPI00317902 0 2 0 2 0 0 4 -   
112 Rhog Rho-related GTP-binding protein RhoG IPI00116558 0 0 0 2 0 2 4 -   CILL GGTase-I + ++
113 Slc38a2 Sodium-coupled neutral amino acid transporter 2 IPI00453817 0 0 0 0 0 4 4 -   
114 Pgrmc2 Membrane-associated progesterone receptor component 2 IPI00351206 0 1 0 0 0 3 4 -   
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3.4 S-farnesylation is crucial for membrane targeting and antiviral 
activity of zinc-finger antiviral protein long-isoform (ZAPL) 
ZAP was originally identified in a rat cDNA overexpression screen for host 
factors that could significantly impair replication of Moloney murine leukemia virus 
(MuLV) as an N-terminal protein fused to the Zeocin resistance marker[98].  This 
original ZAP construct consisting of the first 254 amino acids of rat ZAP (rNZAP) fused 
to the marker (Figure 22a), inhibited the replication of various alphaviruses[99], 
filoviruses[100] and retroviruses[98, 101], but did not affect host susceptibility to other 
viruses such as vesicular stomatitis virus, poliovirus, yellow fever virus and herpes 
simplex virus type 1[99].  Additional experiments suggested that rNZAP did not interfere 
with MuLV entry, viral DNA synthesis and integration, and viral RNA production in the 
nucleus, but decreased the level of posttranscriptional viral mRNA in the cytoplasm[98].  
Similarly, rNZAP inhibited Sindbis virus (SINV) replication by blocking post-entry steps 
of translation and amplification of incoming viral RNA[99].  rNZAP is predominantly 
localized in the cytoplasm at steady state, but shuttles between the cytoplasm and the 
nucleus in a CRM1-dependent manner[102].  rNZAP is also proposed to bind 
cytoplasmic viral mRNA through its second and fourth CCCH-type zinc-fingers[100, 
103], although recent structural studies suggest a role for all 4 zinc-fingers in forming an 
RNA binding groove[104].  ZAP recruits p72 DEAD-box[105] and DHX30 DEXH-
box[106] RNA helicases, and the RNA processing exosome[107] for optimal depletion of 
viral mRNA.  While early ZAP studies were conducted with rNZAP, the analysis of full-
length rat ZAP (rZAP), which bears an additional WWE domain predicted to mediate 
specific protein-protein interactions in ubiquitin and ADP-ribose conjugation 
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systems[108] (Figure 22a), suggests similar antiviral activity against MuLV[98].  Recent 
reports have suggested that human ZAP (hZAP) recruits both the 3’ and 5’ mRNA 
degradation machinery since it binds adenylase poly(A)-specific ribonuclease to remove 
the poly(A) tail and the decapping complex Dcp1a/Dcp2 to remove the cap 
structure[101]. 
There are two ZAP isoforms arising from alternative splicing: ZAP-long (ZAPL) 
and ZAP-short (ZAPS).  Both have the same amino acid sequence but ZAPS lacks the 
carboxyl-terminal poly(ADP-ribose) polymerase (PARP)-like domain present in ZAPL 
(Figure 22a)[109].  Even though the PARP-like domain of ZAPL is predicted to be 
inactive, ZAPL/S isoforms have been annotated as PARP-13.1/2 respectively.  Human 
ZAPL exhibits stronger antiviral activity than hZAPS against MuLV expression and 
Semliki forest virus infection[109], while both isoforms prevent HIV-1 infection[101].  
The ZAP isoforms are relatively broadly expressed in human tissues[109], but the mRNA 
expression of hZAPS is markedly increased by IFNα treatment[110].  hZAPS is also 
more active than hZAPL in enhancing RIG-I-dependent signaling in response to 5’-
triphosphate-modified RNA, suggesting regulation of ZAP activity can enhance or even 
amplify IFN responses[110].  In addition, ZAPS and ZAPL are both polyADP-
ribosylated and been implicated in stablization of mRNA during cellular stress[111].  
Interestingly, ZAPS polyADP-ribosylation is selectively elevated during cellular stress 
compared to ZAPL[111].  These results highlight a potential duality in the regulation and 
functions of ZAP isoforms.  The role of S-prenylation on ZAPL (PARP-13.1/zc3hav1) 
localization and antiviral function has not been investigated.  Here we show S-prenylation 
enhances the membrane targeting and antiviral activity of ZAPL. 
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3.4.1 Long-isoform of ZAP is S-farnesylated 
S-Prenylation of ZAP was investigated further to validate our alk-FOH proteomic 
data and explore the impact of this lipid modification on ZAP subcellular localization and 
antiviral activity.  ZAP amino acid sequence analysis indicates that ZAPL, but not ZAPS, 
bears a carboxyl-terminal CaaX motif for protein prenylation (Figure 22a).  Alk-FOH 
labeling of HEK293T and HeLa cells transfected with plasmids expressing hemagglutinin 
epitope (HA)-tagged mouse ZAP (HA-ZAP) followed by anti-HA immunoprecipitation, 
and CuAAC with az-rho and in-gel fluorescence scanning indicated that ZAPL, but not 
ZAPS, is indeed prenylated (Figure 22b,23a).  Since protein S-prenylation is sometimes 
followed by protein S-palmitoylation to increase membrane affinity[1], we also labeled 
HA-ZAPL-expressing HeLa cells with alk-16, a chemical reporter of palmitoylation[7], 
but palmitoylation of ZAPL was not detected (Figure 23a).  We then evaluated whether 
ZAPL is prenylated at cysteine (Cys) residue 993 of the CaaX motif.  Alk-FOH labeling 
of HEK293T and HeLa cells transfected with a plasmid bearing a Cys-to-serine (Ser) 
mutation in HA-ZAPL, termed HA-ZAPL-SaaX (Figure 22a), showed a significant 
reduction in the level of ZAPL prenylation (Figure 22b,23b).  To assess whether ZAPL is 
farnesylated or geranygeranylated, HEK293T and HeLa cells expressing HA-ZAPL were 
treated with farnesyltransferase or geranylgeranyltransferase-I inhibitors (FTI-297 or 
GGTI-2133, respectively) before alk-FOH labeling.  While GGTI-treated cells had the 
same fluorescence level as non-treated cells, FTI-treated cells showed a marked decrease, 
suggesting the long-isoform of ZAP (ZAPL) is S-farnesylated at Cys993 (Figure 
22c,23c). 
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3.4.2 S-farnesylation controls membrane targeting and cellular localization of ZAPL 
We next investigated if S-farnesylation of ZAPL affected membrane partitioning 
and cellular localization.  For these studies mouse embryonic fibroblasts (MEFs) were 
transfected with HA-ZAPL, HA-ZAPL-SaaX, or HA-ZAPS and fractionated into 
cytoplasmic, membrane and nuclear fractions.  Each fraction was analyzed for ZAP 
distribution by anti-HA immunoblot along with histone H3, calnexin and GAPDH as 
controls for nuclear, membrane and cytoplasmic fractions, respectively (Figure 23d).  
While ZAPS was found in nuclear, membrane and cytosolic fractions, ZAPL was 
markedly depleted from the cytosol (Figure 23d).  This was attributed to S-farnesylation, 
as ZAPL-SaaX was redistributed to the cytosol similar to ZAPS (Figure 23d).  MEFs 
transfected with the HA-ZAP constructs were also analyzed by immunofluorescence 
using confocal microscopy.  While ZAPL exhibited punctate clusters, ZAPL-SaaX 
showed a more diffuse staining, similar to ZAPS (Figure 24a).  Cotransfection of 
plasmids expressing HA-ZAP and cellular markers indicated that ZAPL localizes to 
lysosomes (LAMP1-GFP) and late endosomes (GFP-Rab7), but not early endosomes 
(GFP-Rab5) (Figure 24b).  This localization was not observed with ZAPL-SaaX or ZAPS 
(Figure 25-27).  S-farnesylation is thus required for targeting ZAPL to late endosomal 
and lysosomal compartments. 
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3.4.3 S-farnesylation regulates ZAPL antiviral activity 
We then determined whether isoform-specific S-farnesylation was crucial for 
ZAPL antiviral activity using Sindbis virus (SINV) as a prototypic alphavirus for these 
infection assays (in collaboration with the laboratory of Dr Margaret MacDonald, The 
Rockefeller University).  Since murine ZAP mRNA level is upregulated by type I 
IFN[112] and ZAP exhibits homotypic interactions[113], we utilized Stat1-deficient 
(Stat1-/-) MEFs that are defective in IFN signaling[114] to mitigate the effects of IFN-
induced endogenous ZAP.  Stat1-/- MEFs transfected with HA-ZAP constructs were thus 
infected with a SINV encoding enhanced green fluorescent protein (TE/5’2J/GFP)[115] 
at a multiplicity of infection (MOI) of ~50 for 24 hours before immunostaining and flow 
cytometric analysis of the HA tag (ZAP) and EGFP (virus) expression.  This allowed 
direct comparison of virus infection in transfected and non-transfected cells in the same 
sample by gating on the cells with high and low HA staining, respectively.  Transfected 
Stat1-/- MEFs with low HA staining were infected at comparable levels (26-28%) to 
vector control samples (32%) (Figure 28a, lower quadrants; Figure 28b, grey). In 
addition, transfected cells expressed similar levels of different HA-ZAP proteins, as 
determined by the percentage of cells with high HA staining and the mean fluorescence 
intensity (MFI) of those cells (Figure 28a, upper quadrants).  Only 5% of HA-ZAPL 
expressing Stat1-/- MEFs were infected while cells expressing the non-farnesylated HA-
ZAPL-SaaX and HA-ZAPS proteins had higher levels of infected cells (14-15%; student 
t-test: P = 0.00016 and 0.00003, respectively) (Figure 28b, black).  ZAPL inhibited SINV 
to a significantly greater extent than ZAPS (Figure 28c), with ZAPS demonstrating only 
65% of the antiviral activity of ZAPL.  This is consistent with previous ZAP studies with 
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MuLV[109].  This increased antiviral activity is mostly attributed to ZAPL S-
farnesylation, since HA-ZAPL-SaaX expression resulted in infected cell levels similar to 
HA-ZAPS (Figure 28b,c).  The S-farnesylation-dependent antiviral activity of ZAPL was 
also observed at a lower MOI (Figure 29a,b) and in HEK293T cells (Figure 29c-f).  
These results demonstrate S-farnesylation significantly enhances the antiviral activity of 
ZAPL. 
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CHAPTER IV. Discussion 
4.1 Improvements in detection of lipidated proteins 
The installation of lipids onto proteins is a fundamental posttranslational 
modification that controls a wide variety of biological pathways but has been challenging 
to study.  To address the limitations in the visualization of lipidated proteins, we have 
synthesized fatty acid and isoprenoid chemical reporters that allow rapid metabolic 
labeling of cells and robust fluorescence detection of lipidated proteins using 
bioorthogonal labeling methods.  A comparative analysis of lipidated chemical reporters 
and bioorthogonal labeling methods revealed that alkynyl-fatty acids or alkynyl-farnesol 
in combination with azide-functionalized fluorophores afford the most sensitive method 
for the visualization of fatty-acylated and prenylated proteins, respectively, after CuAAC 
and in-gel fluorescence scanning.  The in-gel fluorescence detection of lipidated proteins 
circumvents the need to transfer proteins onto membranes for immunoblotting, which can 
be problematic for hydrophobic polypeptides, and thus provides a more direct and 
quantitative means to analyze lipidated proteins.  The sensitivity of this chemical 
approach enables robust detection of lipidated proteins within minutes after gel-
electrophoresis compared to days or weeks with radioactive analogs, such that fatty-
acylated and prenylated proteins expressed at endogenous levels can be readily 
visualized.  The advances described here present significant improvements in the 
detection of protein lipidation compared to previously reported methods, which allowed 
the visualization of fatty-acylated proteins from primary tissues after metabolic labeling 
of living animals for the first time.  Our approach also enabled the detection of 
Salmonella bacterial effector SifA, SspH2 and SseI palmitoylation and of Legionella 
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bacterial effectors prenylation in cells for the first time.  Proteomic analysis of lipidated 
proteins was also improved such that we were able to enrich and identify new candidate 
lipidated proteins such as antiviral IFITM3 and ZAP.  Our alkynyl-lipid chemical 
reporters therefore present new opportunities to dissect the functions of protein fatty-
acylation and prenylation in physiology and disease. 
4.2 Current limitations of lipid chemical reporters 
As demonstrated by our proteomics experiments, alkynyl-lipid chemical reporters 
label enzymes associated with lipid synthesis and metabolism in addition to lipidated 
proteins.  To evaluate the effect of degradation of chemical reporters of protein fatty 
acylation, we have recently synthesized 15-hexadecynyloxyacetic acid (HDYOA), a 
reporter that was designed to be resistant to β-oxidation based upon the molecular 
mechanism of fatty-acid metabolism, and we evaluated whether HDYOA could 
differentially target fatty-acylated proteins compared to metabolic enzymes[116].  
HDYOA was able to label known candidate S-palmitoylated proteins similarly to ODYA.  
Accordingly, bioorthogonal proteomic analysis demonstrated that 70% of proteins 
labeled with alk-16 were also labeled with HDYOA.  However, the proteins observed 
differentially in our proteomic studies suggested that a portion of alk-16 protein labeling 
is a result of β-oxidation.  In contrast, downstream enzymes involved in β-oxidation of 
fatty acids were not targeted by HDYOA.  Since HDYOA can label S-palmitoylated 
proteins and is not utilized by downstream β-oxidation pathways, this fatty acid chemical 
reporter may be particularly useful for bioorthogonal proteomic studies in cell types 
metabolically skewed toward fatty acid breakdown.  This approach could also be applied 
to prevent the degradation of other chemical reporters. 
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4.3 Analysis of SifA prenylation in cells 
The differences in SifA prenylation between our results and previous studies may 
be due to cellular labeling with alk-FOH compared to in vitro labeling with 
[3H]mevalonic acid.  The improved fluorescence detection with alk-FOH in cells may 
reveal low levels of S-prenylation not visualized by [3H]mevalonic acid in vitro.  
Prenylation analyses of proteins bearing the unusual double cysteine CCXX C-terminal 
motif similar to SifA have been described.  Geranylgeranyl modification of Rab5A 
(CCSN) is catalyzed by an enzyme in brain cytosol but not by purified GGTase I[117].  
Similarly, Rab5A prenylation with GGTase II/REP-1 and [3H]GGPP followed by mass 
spectrometry analysis demonstrated that Rab5A is geranylgeranylated on both cysteines 
by GGTase II[118].  However, the CCXX motif is not always a marker for GGTase II 
substrates: in vitro translational analyses by radioactive labeling in rabbit reticulocyte 
lysate demonstrated that both Ral-A (CCIL) and Ral-B (CCLL) are geranylgeranylated 
exclusively at the cysteine in the fourth position from the carboxyl terminus and 
[3H]GGPP incorporation onto RalA/B could be blocked with GGTase I inhibitors[119-
120].  Alternatively, Wrch-1, a Rho family GTPase bearing a CCFV C-terminal motif 
and a brain-specific isoform of Cdc42 with a CCIF motif were not to be prenylated, but 
instead S-fatty acylated[121-122].  CCXX can therefore be a motif for prenylation and S-
palmitoylation.  Nonetheless, our analyses of SifA prenylation with inhibitors of 
prenyltransferases and cysteine mutants suggest that SifA may be heterogeneously 
prenylated in host cells and single cysteine mutations do not completely abolish S-
prenylation.  While our cellular alk-FOH labeling of SifA differ from in vitro 
[3H]mevalonic acid labeling studies, the robust and heterogeneous SifA prenylation from 
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our alk-FOH cellular labeling is consistent with residual membrane partitioning of these 
SifA mutants as well as their activity during Salmonella infection[36]. 
4.4 Analysis of isoform-specific farnesylation of ZAPL 
Prenylation provides an essential membrane targeting mechanism that controls the 
functions of many proteins in eukaryotic biology.  The direct biochemical analysis of 
these lipidated proteins can therefore reveal important activities in cellular membranes 
not readily apparent by monitoring protein expression alone.  The application of an 
alkyne-farnesol reporter and improved bioorthogonal proteomics described here has 
enabled large-scale proteomic analysis of known prenylated proteins such as small 
GTPases as well as unannotated substrates like ZAPL.  Our discovery and 
characterization of ZAPL lipidation demonstrates that S-farnesylation enhances the 
endolysosomal membrane targeting and inhibitory activity of this antiviral protein against 
SINV. 
How ZAPL S-farnesylation promotes clustering to endosomes and lysosomes 
remains to be addressed.  Prenylated proteins are constitutively excluded from detergent-
resistant domains[123], which are lipid-ordered domains rich in cholesterol content.  
Although synthesis of cholesterol occurs in the ER, cholesterol is actively transported to 
the plasma membrane (PM) through the secretory pathway such that the PM is the 
cellular membrane with the highest cholesterol content[124].  While the ER and Golgi 
apparatus are continuously depleted of cholesterol from its transport to the PM, early 
endosomes have a cholesterol content similar to the PM as they bud off, and gradually 
decrease in cholesterol content as they mature to late endosomes and lysosomes[125].  By 
analogy, S-farnesylation-dependent clustering of ZAPL to endolysosomes could be 
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attributed to the increasing depletion of cholesterol in the endocytic pathway, and thus 
promote the localization of ZAPL at the site of entry of alphaviruses viral RNA.  How 
ZAPL reaches endolysosomal membranes also remains unanswered.  Is ZAPL passively 
diffusing from the cytosol to membranes or is it transported through the secretory 
pathway?  These questions remain to be answered. 
As ZAP is thought to inhibit SINV infection after virus entry but before 
amplification of newly synthesized plus strand genomic RNA[99], membrane targeting 
may place ZAPL near sites of membrane fusion to immediately target incoming viral 
RNA.  Early SINV replication has now been observed in plasma membrane-associated 
cytopathic vacuoles (CV), which can then be transported into the cytosol in association 
with endosome-like vesicular organelles at a later stage of infection[126].  The S-
farnesylated and membrane-associated ZAPL may therefore also interfere with assembly 
and replication of SINV as well as other viruses[98, 100-101], which have likewise been 
reported to assemble on cellular membranes[127].  Lipidation and membrane-association 
of ZAPL likely also contributes the differential activity of this long-isoform compared to 
ZAPS, which does not interfere with MuLV entry, viral DNA synthesis and integration, 
and viral RNA production in the nucleus, but decreased posttranscriptional viral mRNA 
in the cytoplasm[98] and is more active in enhancing RIG-I-dependent sensing of viral 
RNA[110].  These results suggest that S-farnesylated ZAPL exhibits a unique antiviral 
activity on cellular membranes, which may be important for the development of new 
antiviral strategies.  Finally, these studies highlight how bioorthogonal proteomics of 
protein S-prenylation can reveal new insights into host-pathogen interactions that should 
be useful for exploring other biological pathways and human diseases.  
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CHAPTER V. Experimental methods 
5.1 Plasmids construction 
The human HA-RasG12V construct was a gift from Prof. Marilyn Resh (Memorial 
Sloan-Kettering Cancer Center), GFP-RhoA (plasmid 12965) and GFP-Rab7 (plasmid 
12605) constructs were acquired from Addgene.  ZAP-L was cloned from an interferon 
induced mouse dendritic cell (DC 2.4) cDNA library by PCR using sense primer ZAPL-
SP: 5’-GGCCGTCGACCATGACGGATCCCGAGGTATTC-3’ and antisense primer 
ZAPL-AP: 5’-GGCCGCGGCCGCCTAACTAATTATGCATCCTT-3’.  The sense 
primer introduces a SalI site (bolded) immediately upstream from the coding sequence as 
well as a nucleotide for in frame expression and the antisense primer introduces a NotI 
site (bolded) immediately downstream from the coding sequence to facilitate its cloning 
into the pCMV-HA mammalian expression vector (Clontech), yielding N-terminal HA-
tagged ZAPL fusion (pCMV-HA-ZAPL).  Mutagenesis was performed using the 
Stratagene Quikchange Multi Site-Directed Mutagenesis Kit on pCMV-HA-ZAPL 
template.  Primers used for mutations are as follows: pCMV-HA-ZAPS: 5’-
CTGGGGCATCACTGGCTGCTACTCTGGACCTCTTCTCTTCTG-3’, pCMV-HA-
ZAPL-SaaX: 5’-GAGAAAGAGAAAGGATCTATAATTAGTTAGGCG-3’. 
5.2 Cell culture, transfections and metabolic labeling 
Jurkat cells were cultured in RPMI medium 1640, while all other cells were 
cultured in DMEM, both supplemented with 10% fetal bovine serum (FBS), 100 U/mL 
penicillin and 100 μg/mL streptomycin.  Cells were maintained in a humidified 37 °C 
incubator with 5% CO2.  HEK293T cells were transfected using X-tremeGENE 9 DNA 
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Transfection Reagent (Roche) while HeLa cells and MEFs were transfected using 
Lipofectamine 2000 (Invitrogen).  Cells were treated with lipid reporters using the same 
volume of DMSO in the negative controls.  For coincubation with inhibitors, cells were 
pretreated for 1 hour with the inhibitors prior to lipid reporter addition.  Cells were then 
harvested, washed twice with ice-cold PBS and pelleted at 1000g for 5 min.  Cells were 
directly lysed or flash frozen in liquid nitrogen and stored at -80 °C prior to lysis.  Cell 
fractionation was performed with Qproteome Cell Compartment Kit (Qiagen, 37502) 
following manufacturer procedure. 
Spleens were harvested from 6 week-old female C57/BL6 mice.  Splenocytes 
were prepared by manual disruption of spleens using forceps.  Red blood cells were 
eliminated using ACK lysis buffer.  Splenocytes were pelleted and resuspended in either 
alk-12 or alk-16 (20 M, 50 mM stock solution in DMSO) in RPMI medium 1640 
supplemented with 2% FBS, 100 U/mL penicillin, and 100 g/mL streptomycin using 
one spleen per labeling condition.  The same volume of DMSO was used as a negative 
control.  After 4-6 hours of labeling at 37 °C, the cells were pelleted at 1,000 g for 5 
minutes, washed once with ice-cold PBS, and directly lysed. 
5.2.1 Alkynyl-fatty acid in vivo labeling in mice 
PBS containing 10% fatty acid free BSA (Sigma) was added to alk-12 and alk-16 
(25 mg/mL), followed by brief sonication, warming to 37 °C, and IP injection of 200 L 
into 6 week-old female C57/BL6 mice for 1 hour.  Livers and kidney were harvested and 
incubated with Liberase 3 Blendzyme (Roche) at 37 °C for 30 min and homogenized 
prior to filtration with 0.4 m cell strainers.  Splenocytes were prepared by manual 
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disruption of spleens using forceps.  Liver, kidney and splenocyte preparations were 
subjected to red blood cell lysis using ACK lysis buffer.  Cells were pelleted at 1,000 g 
for 5 minutes, washed once with ice-cold PBS, and directly lysed. 
5.3 Immunoprecipitation 
Cell pellets obtained from 3 confluent wells of a 6-well plate were lysed with 150 
L of ice-cold Brij lysis buffer (1% Brij 97, 50 mM triethanolamine pH 7.4, 150 mM 
NaCl, 5× EDTA-free Roche protease inhibitor cocktail, 10 mM PMSF).  Cell lysates 
were collected after centrifuging at 1000g for 5 min at 4 °C to remove cell debris.  
Protein concentration was determined by the BCA assay (Pierce).  Proteins of interest 
were immunoprecipitated from 400 g protein cell lysates in 250 L ice-cold Brij lysis 
buffer using one of the following antibodies: mouse anti-Lck (p56lck) monoclonal (Clone 
3A5, Thermo Scientific), rabbit anti-LAT polyclonal (Upstate), rabbit anti-Fyn 
polyclonal (Upstate), anti-GFP rabbit pAb (ab290, Abcam) and 25 L of packed protein 
A-agarose beads (Roche) per sample, or 15 L of packed anti-v-H-ras (Ab-1) rat mAb 
(Y13-259) agarose conjugate (Calbiochem) or 25 L of packed anti-HA (HA-7) mouse 
mAb agarose conjugate (Sigma).  Upon incubation at 4 °C for 2 hours with a nutating 
mixer (Labnet), the beads were washed (3 x 1 mL) with ice-cold modified RIPA lysis 
buffer (1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 50 mM triethanolamine 
pH 7.4, 150 mM NaCl). 
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5.4 Bioorthogonal ligation 
5.4.1 Staudinger ligation 
Cell lysates (50 g) in 46.5 L modified RIPA lysis buffer were reacted with 1 
L phosphine-biotin[128] (200 M, 10 mM stock solution in DMSO) and 2.5 L DTT (5 
mM, 100 mM stock solution in deionized water) for a total reaction of volume of 50 L 
for 1 hr at room temperature.  DTT prevents non-specific oxidation of phosphine-biotin, 
which can increase levels of background labeling.  The reactions were terminated by the 
addition of -20 °C methanol (1 mL) and placed at -20 °C for at least 1 hr, centrifuged at 
18,000 g for 10 min at 0 °C to precipitate proteins.  The supernatant from the samples 
were discarded.  The protein pellets were allowed to air dry for 10 min, resuspended in 35 
L of resuspension buffer (4% SDS, 50 mM triethanolamine pH 7.4, 150 mM NaCl), 
diluted with 12.5 L 4X reducing SDS-loading buffer (40% glycerol, 200 mM Tris-HCl 
pH 6.8, 8% SDS, 0.4% bromophenol blue) and 2.5 L 2-mercaptoethanol, heated for 5 
min at 95 ºC and ~20 g of protein was loaded per gel lane for separation by SDS-PAGE 
(10% or 4-20% Bio-Rad Criterion Tris-HCl gel). 
5.4.2 CuI-catalyzed azide-alkyne cycloaddition (CuAAC) 
For immunoprecipitations, the purified protein bound to beads was suspended in 
50 L of ice-cold PBS, to which was added 3 μL freshly premixed CuAAC reaction 
cocktail [azido-rhodamine (100 μM, 10 mM stock solution in DMSO), tris(2-
carboxyethyl)phosphine hydrochloride (TCEP) (1 mM, 50 mM freshly prepared stock 
solution in deionized water), tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) 
(100 μM, 10 mM stock solution in DMSO) and CuSO4·5H2O (1 mM, 50 mM freshly 
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prepared stock solution in deionized water)] for 1 h at 4 °C on a nutating mixer.  The 
beads were washed (3 x 1 mL) with ice-cold modified RIPA lysis buffer, resuspended in 
40 μL loading buffer [27.5 L (4% SDS, 50 mM triethanolamine pH 7.4, 150 mM NaCl), 
10 L 4× SDS-loading buffer (40% glycerol, 200 mM Tris-HCl pH 6.8, 8% SDS, 0.4% 
bromophenol blue) and 2.5 μL 0.5 M Bond-Breaker TCEP Solution (Thermo Scientific)], 
heated for 5 min at 95 °C, and 20 μL of the supernatant was loaded on 2 separate SDS-
PAGE gels (4−20% Bio-Rad Criterion Tris-HCl gel), one for fluorescence detection and 
the other for immunoblotting. 
For cell lysates, 50 g proteins were conjugated in 47 l SDS-buffer (4% SDS, 50 
mM triethanolamine pH 7.4, 150 mM NaCl) with 3 μL freshly premixed CuAAC 
reaction cocktail (same as above) for 1 hour at room temperature.  Proteins were 
precipitated by adding ice-cold methanol (1 mL), placing at -80 °C overnight, 
centrifuging at 18000g for 10 min at 4 °C and discarding the supernatant.  The protein 
pellets were allowed to air-dry, resuspended in 50 μL loading buffer (same as above), 
heated for 5 min at 95 °C, and 20 μg of protein was loaded on 2 separate SDS-PAGE 
gels. 
5.5 Hydroxylamine cleavage of S-acylated proteins 
After the proteins were separated by SDS-PAGE, the gel was soaked in 40% 
MeOH, 10% acetic acid, shaking overnight at room temperature, washed with deionized 
water (2 x 5 minutes) and scanned for the pre-hydroxylamine treatment fluorescence.  
The gel was then soaked in PBS, shaking 1 hour at room temperature, followed by 
soaking in 1 M NH2OH (pH = 7.4), shaking 8 hours at room temperature, washing with 
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deionized water (2 x 5 minutes), and soaking in 40% MeOH, 10% acetic acid, shaking 
overnight at room temperature.  The gel was finally washed with deionized water (2 x 5 
minutes) and scanned for the post-hydroxylamine treatment fluorescence. 
5.6 In-gel fluorescence imaging 
After SDS-PAGE separation, the gel was soaked in destaining solution (40% 
MeOH, 10% acetic acid, 50% H2O) overnight at 4 °C on an orbital shaker, rehydrated 
with deionized water and visualized scanning the gel on an Amersham Biosciences 
Typhoon 9400 variable mode imager (excitation 532 nm, 580 nm filter, 30 nm band-
pass). 
5.7 Immunoblotting 
Proteins separated by SDS-PAGE were transferred (50 mM Tris, 50 mM glycine, 
0.1% SDS, 10% MeOH in deionized water, Bio-Rad Trans-Blot Semi-Dry Cell, 20 V, 45 
min) onto a nitrocellulose membrane (0.45 m, Bio-Rad) which was subsequently 
blocked (10% non-fat dried milk, 2% BSA and 0.1% Tween-20 in PBS) overnight at 4 °C 
on an orbital shaker.  The membrane was washed thrice with PBST (0.1% Tween-20 in 
PBS), and incubated with one of the following primary antibodies: mouse anti-Lck 
(p56lck) monoclonal (Clone 3A5, Thermo Scientific), mouse anti-LAT monoclonal (2E9, 
Upstate), mouse anti-Fyn monoclonal (S1, Chemicon), anti-Ras (RAS10) mouse mAb 
(1:4000, Upstate), anti-HA (HA-7) mouse mAb (1:2000, Sigma), anti-GFP (JL-8) mouse 
mAb (1:1000, Clontech), rabbit anti-histone H3 (1/2,000, 06-755, Millipore), rabbit anti-
calnexin (1/1,500, ab22595, Abcam) or rabbit anti-GAPDH (1/5,000, ab70699, Abcam) 
for 1 hour at room temperature in PBST.  The membrane was washed thrice with PBST, 
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incubated with one of the following secondary antibodies: anti-mouse (H+L) donkey 
HRP-conjugated antibody (Jackson IR, 1:15000) or HRP-conjugated goat anti-rabbit 
(1/15,000, 12-348, Millipore) for 1 hour at room temperature in 5% non-fat dried milk 
and 1% BSA in PBST, washed thrice with PBST, and subsequently developed with ECL 
Western blotting detection reagents (Thermo Scientific).  For Staudinger ligation, the 
membrane was blocked, incubated with streptavidin-horseradish peroxidase (1 mg/mL 
diluted 1:25,000 in PBST, Pierce), and subsequently developed with ECL Western 
blotting detection reagents (Amersham). 
5.8 Prenylome profiling 
5.8.1 Enrichment of alk-FOH labeled proteins 
RAW264.7 macrophages were pre-treated with lovastatin (10 μM, 12 hrs), then 
alk-FOH was added (50 μM, 12 hrs), cells were harvested, lysed in 1 mL ice-cold 
hypotonic buffer (5 mM triethanolamine pH 7.4, 5 mM MgCl2, EDTA-free Roche 
protease inhibitor cocktail, 1 mM PMSF) and solubilized by dilution with 1 mL of 2X-
SDS buffer (8% SDS, 100 mM triethanolamine pH 7.4, 300 mM NaCl) + 2 μL 
Benzonase nuclease (E1014, Sigma).  Cell lysates (20 mg) were then reacted with az-azo-
biotin[94] in 20 mL with CuAAC reactants (same as above) for 2 hours at room 
temperature.  Methanol-precipitated and washed protein pellets were resuspended in 2 
mL 1X-SDS buffer + 10 mM EDTA. 15 mg of proteins were diluted with 8 mL Brij 
buffer (1% Brij 97, 50 mM triethanolamine pH 7.4, 150 mM NaCl) and incubated with 
300 μL prewashed streptavidin-agarose beads (20357, Thermo Scientific) for 1 h at room 
temperature.  The beads were washed once with PBS + 1% SDS, thrice with PBS, and 
twice with ABC buffer (50 mM ammonium bicarbonate).  The beads were incubated in 
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500 μL ABC buffer + 8 M urea + 10 mM TCEP + 20 mM iodoacetamide for 0.5 h at 
room temperature, and then washed twice with ABC buffer.  Proteins were eluted by 
incubating the beads twice in 250 μL ABC buffer + 1% SDS + 25 mM Na2S2O4 for 1 h at 
room temperature.  Proteins from the pooled supernatants were concentrated using an 
Amicon Ultracel-10K (UFC501096, Millipore).  Samples were then subjected to SDS-
PAGE and staining with Coomassie blue.  DMSO and alk-FOH lanes of the gel were then 
cut for trypsin digestion and peptide extraction.  Extracted peptides were dried and 
resuspended in H2O + 0.1% trifluoroacetic acid for mass spectrometry. 
5.8.2 LC-MS/MS analysis 
LC-MS/MS analysis was performed with a Dionex 3000 nano-HPLC coupled to 
an LTQ-Orbitrap ion trap mass spectrometer (ThermoFisher).  Peptides were pressure-
loaded onto a custom-made 75 μm diameter, 15 cm C18 reverse-phase column and 
separated with a gradient running from 95% buffer A (H2O + 0.1% formic acid) and 5% 
buffer B (CH3CN + 0.1% formic acid) to 55% buffer B over 30 min, next ramping to 
95% buffer B over 10 min and holding at 95% buffer B for 10 min.  One full MS scan 
(300-2,000 MW) was followed by three data-dependent scans of the nth most intense ions 
with dynamic exclusion enabled. 
5.8.3 Database searching 
Tandem mass spectra from three independent experiments were extracted by 
BioWorks (Thermo Scientific, version 3.3.1 SP1).  All MS/MS samples were analyzed 
using Sequest (Thermo Scientific, SRF v. 5) and X! Tandem (TORNADO, 
2010.01.01.5). Sequest and X! Tandem were set up to search the mouse International 
Protein Index (IPI) protein sequence database (version 3.83, 60010 entries) assuming the 
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digestion enzyme trypsin and allowing 2 missed cleavage sites per peptide.  Sequest and 
X! Tandem were searched with a fragment ion mass tolerance of 1.00 Da and a parent ion 
tolerance of 10.0 PPM.  Deamidation of asparagine and glutamine, oxidation of 
methionine and tryptophan, acetylation of the n-terminus and iodoacetamide derivative of 
cysteine were specified as variable modifications, allowing 3 modifications per peptide. 
5.8.4 Criteria for protein identification 
Scaffold (Proteome Software, version 3.00.04) was used to validate MS/MS based 
peptide and protein identifications.  Peptide identifications were accepted if they could be 
established at greater than 95.0% probability as specified by the Peptide Prophet 
algorithm[129].  Peptide identifications were also required to exceed specific database 
search engine thresholds.  Sequest identifications required at least ΔCn scores of greater 
than 0.10 and XCorr scores of greater than 1.8, 2.5, 3.5 and 3.5 for singly, doubly, triply 
and quadruply charged peptides.  X! Tandem identifications required at least -Log(Expect 
Scores) scores of greater than 2.0.  Protein identifications were accepted if they could be 
established at greater than 99.9% probability and contained at least 2 identified peptides.  
Protein probabilities were assigned by the Protein Prophet algorithm[130].  Proteins that 
contained similar peptides and could not be differentiated based on MS/MS analysis 
alone were grouped to satisfy the principles of parsimony.  Proteins were considered 
high- or medium-confidence hits based on their number of assigned spectra. 
5.9 Microscopy 
For determination of ZAP localization, transfected HEK293T or MEF cells were 
fixed with PBS + 3.7% paraformaldehyde, permeabilized with PBS + 0.1% Triton X-100 
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and blocked with PBS + 2% FBS.  Cells were then incubated with anti-HA antibody 
(1/1,000, H3663, Sigma), washed thrice, and stained with goat anti-mouse antibody 
conjugated to Rhodamine Red-X (1/1,000, R6393, Invitrogen).  Cells were incubated 
with TOPRO-3 (1/1,000, Invitrogen) as a final step.  Confocal images were collected 
using a Zeiss LSM 510 laser scanning confocal microscope equipped with a Plan-
Apochromat 100X/1.40 oil objective. 
5.10 Virus infections and flow cytometry 
293T or Stat1 -/- MEF cells expressing ZAP constructs were infected for 24 hours 
with Sindbis virus encoding the enhanced green fluorescent protein (EGFP) from a 
duplicated subgenomic promoter (TE/5′2J/GFP)[115].  Stocks were prepared and titers 
determined on BHK-J cells with 10-fold serial dilutions of sample, and then plaques were 
visually enumerated after crystal violet staining, as previously described[99].  
Multiplicities of infection (MOI) were calculated based on BHK-J-derived titers, and 
approximately 10-fold virus titers were necessary for equivalent levels of MEF 
infections.  For flow cytometry, cells were fixed with PBS + 3.7% paraformaldehyde, 
then permeabilized and blocked with PBS + 0.1% Triton X-100 + 2% FBS.  Cells were 
then incubated with mouse anti-HA antibody (1/1,000, H3663, Sigma), washed thrice, 
and stained with goat anti-mouse antibody conjugated to Rhodamine Red-X (1/1,000, 
R6393, Invitrogen).  Results were analyzed with FlowJo software. 
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5.11 Synthesis of chemical reporters and secondary tags 
5.11.1 General procedures 
All chemicals were obtained either from Sigma-Aldrich, MP Biomedicals, Alfa 
Aesar, TCI, Fluka or Acros and were used as received unless otherwise noted.  The silica 
gel used in flash column chromatography was Fisher S704 (60-200 Mesh, 
Chromatographic Grade).  Analytical thin layer chromatography (TLC) was conducted 
on Merck silica gel plates with fluorescent indicator on glass (5-20 m, 60 Å) with 
detection by ceric ammonium molybdate, basic KMnO4 or UV light.  The 1H and 13C 
NMR spectra were obtained on a Bruker DPX-400 spectrometer or a Bruker AVANCE-
600 spectrometer equipped with a cryoprobe.  Chemical shifts are reported in  ppm 
values downfield from tetramethylsilane and J values are reported in Hz.  MALDI-TOF 
mass spectra were obtained on an Applied Biosystems Voyager-DE.  LC/MS were 
obtained on a Waters 500E pump and controller equipped with a Waters XBridge C18 5 
m 4.6 x 150 mm column, Waters 996 photodiode array detector and Waters Micromass 
ZQ mass spectrometer and the samples were single peak purity. 
5.11.2 Alkynyl-fatty acids synthesis 
Alkynyl-fatty acids were synthesized according to reported procedures[131-132] 
and were identical by 1H NMR analysis. 
Tetradec-13-ynoic acid (alk-12):  1H NMR (400 MHz, CDCl3):  1.22-1.30 (s, 
14H), 1.29-1.70 (m, 4H), 1.96 (t, 1H, J = 4), 2.22 (dt, 2H, J = 4, 7), 2.36 (t, 2H, J = 7). 
Hexadec-15-ynoic acid (alk-14):  1H NMR (400 MHz, CDCl3):  1.22-1.30 (s, 
18H), 1.29-1.70 (m, 4H), 1.96 (t, 1H, J = 4), 2.22 (dt, 2H, J = 4, 7), 2.36 (t, 2H, J = 7). 
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Octadec-17-ynoic acid (alk-16):  1H NMR (600 MHz, CDCl3):  1.22-1.30 (m, 
18H), 1.29-1.35 (m, 2H), 1.35-1.42 (m, 2H), 1.52 (qu, 2H, J = 7.1), 1.63 (qu, 2H, J = 
7.5), 1.93 (t, 1H, J = 2.6), 2.18 (dt, 2H, J = 2.6, 7.1), 2.35 (t, 2H, J = 7.5). 
5.11.3 Alkynyl/azido-isoprenoids synthesis 
(2E,6E,10E)-2,6,10-trimethyl-12-((tetrahydro-2H-pyran-2-yl)oxy)dodeca-
2,6,10-trien-1-ol (4) was produced according to published literature protocols and was 
identical to previously reported 1H, 13C NMR and MS analyses[71].  1H NMR (600 MHz, 
CDCl3):  1.47-1.88 (m, 6H), 1.59 (s, 3H), 1.65 (s, 3H), 1.67 (s, 3H), 1.98-2.15 (m, 8H), 
3.46 (ddd, 1H, J = 5.3, 5.3, 10.6), 3.83 (ddd, 1H, J = 2.9, 8.2, 11.1), 3.91 (s, 2H), 3.97 
(dd, 1H, J = 7.6, 11.9), 4.17 (dd, 1H, J = 6.4, 11.9), 4.58 (t, 1H, J = 3.6), 5.06 (t, 1H, J = 
6.8), 5.30 (t, 1H, J = 6.9), 5.32 (t, 1H, J = 6.9).  13C NMR (150 MHz, CDCl3):  13.8, 
16.1, 16.5, 19.7, 25.6, 26.2, 26.3, 30.8, 39.4, 39.7, 62.4, 63.8, 69.1, 97.9, 120.8, 124.4, 
126.0, 134.7, 135.0, 140.2.  MS: calculated 322.25, found 345.33 [M+Na]+. 
2-(((2E,6E,10E)-3,7,11-trimethyl-12-(prop-2-yn-1-yloxy)dodeca-2,6,10-trien-
1-yl)oxy)tetrahydro-2H-pyran (5) was produced according to published literature 
protocols and was identical to previously reported 1H and 13C NMR analyses[133].  1H 
NMR (600 MHz, CDCl3):  1.47-1.88 (m, 6H), 1.59 (s, 3H), 1.63 (s, 3H), 1.66 (s, 3H), 
1.98-2.15 (m, 8H), 2.39 (t, 1H, J = 2.4), 3.50 (ddd, 1H, J = 5.2, 5.2, 10.4), 3.88 (ddd, 1H, 
J = 3.0, 8.0, 11.1), 3.92 (s, 2H), 4.01 (dd, 1H, J = 7.4, 11.9), 4.06 (d, 2H, J = 2.4), 4.22 
(dd, 1H, J = 6.4, 11.9), 4.61 (t, 1H, J = 3.6), 5.10 (t, 1H, J = 6.7), 5.35 (t, 1H, J = 6.9), 
5.41 (t, 1H, J = 6.9).  13C NMR (150 MHz, CDCl3):  14.0, 16.0, 16.5, 19.7, 25.6, 26.3, 
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26.4, 30.8, 39.3, 39.7, 56.3, 62.4, 63.7, 74.2, 75.9, 80.1, 97.9, 120.7, 124.4, 129.5, 131.2, 
134.9, 140.3.  MS: calculated 360.27, found 383.42 [M+Na]+. 
(2E,6E,10E)-3,7,11-trimethyl-12-(prop-2-yn-1-yloxy)dodeca-2,6,10-trien-1-ol 
(alk-FOH) was produced according to published literature protocols and was identical to 
previously reported 1H, 13C NMR and MS analyses[133].  1H NMR (600 MHz, CDCl3):  
1.60 (s, 3H), 1.65 (s, 3H), 1.68 (s, 3H), 2.00-2.17 (m, 8H), 2.40 (t, 1H, J = 2.4), 3.93 (s, 
2H), 4.07 (d, 2H, J = 2.4), 4.15 (d, 2H, J = 6.9), 5.11 (ddd, 1H, J = 1.2, 6.8, 6.8), 5.39-
5.44 (m, 2H).  13C NMR (150 MHz, CDCl3):  14.1, 16.1, 16.4, 26.4, 26.5, 39.3, 39.6, 
56.4, 59.5, 74.2, 76.0, 80.2, 123.5, 124.3, 129.5, 131.3, 135.1, 139.8.  MS: calculated 
276.21, found 299.33 [M+Na]+. 
2-(((2E,6E,10E)-12-bromo-3,7,11-trimethyldodeca-2,6,10-trien-1-
yl)oxy)tetrahydro-2H-pyran (6): In a previously flame-dried round-bottom flask under 
argon atmosphere was dissolved N-bromosuccinimide (498 mg, 2.80 mmol) in anhydrous 
dichloromethane (8 mL) cooled to 0 °C.  Dimethyl sulfide (247 L, 3.36 mmol) was 
added dropwise over 3 minutes, and the resulting reaction mixture was cooled to -20 °C.  
(4) (603 mg, 1.87 mmol) dissolved in anhydrous dichloromethane (4 mL) was then added 
dropwise over 3 minutes, and the reaction mixture was stirred at 0 °C for 3 hours and 
then overnight at room temperature.  The reaction was quenched with a saturated brine 
aqueous solution and extracted with dichloromethane (3 x 50 mL).  The combined 
organic layers were dried over Na2SO4, filtered and concentrated under reduced pressure.  
The crude material was purified by silica gel flash chromatography (5% EtOAc / 95% 
hexanes) to yield (6) (317 mg, 44%) as a yellow oil.  1H NMR (600 MHz, CDCl3):  
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1.45-1.87 (m, 6H), 1.58 (s, 3H), 1.66 (s, 3H), 1.73 (s, 3H), 1.97-2.14 (m, 8H), 3.49 (ddd, 
1H, J = 5.3, 5.3, 10.6), 3.88 (ddd, 1H, J = 3.0, 7.9, 11.1), 3.95 (s, 2H), 4.01 (dd, 1H, J = 
7.4, 11.9), 4.22 (dd, 1H, J = 6.4, 11.9), 4.61 (t, 1H, J = 3.7), 5.09 (t, 1H, J = 6.8), 5.34 (t, 
1H, J = 6.3), 5.56 (t, 1H, J = 6.8).  13C NMR (150 MHz, CDCl3):  14.7, 16.0, 16.5, 19.7, 
25.6, 26.3, 26.9, 30.8, 38.8, 39.6, 41.9, 62.3, 63.7, 97.9, 120.8, 124.6, 131.3, 132.0, 134.5, 
140.1.  MS: calculated 384.17, found 407.33 [M+Na]+. 
Trimethyl((4E,8E,12E)-4,8,12-trimethyl-14-((tetrahydro-2H-pyran-2-
yl)oxy)tetradeca-4,8,12-trien-1-yn-1-yl)silane (7): In a previously flame-dried round-
bottom flask under argon atmosphere was dissolved trimethylsilylacetylene (46 L, 0.332 
mmol) in anhydrous DMF (1 mL) at room temperature.  Potassium carbonate (46 mg, 
0.332 mmol), sodium sulfite (21 mg, 0.166 mmol), (6) (85 mg, 0.221 mmol) and 
copper(I) iodide (2 mg, 0.011 mmol) were added sequentially and the reaction mixture 
was stirred for 4 hours.  The reaction was quenched with a saturated ammonium chloride 
aqueous solution and extracted with dichloromethane (3 x 50 mL).  The combined 
organic layers were dried over Na2SO4, filtered and concentrated under reduced pressure.  
The crude material was purified by silica gel flash chromatography (5% EtOAc / 95% 
hexanes) to yield (7) (39 mg, 44%) as a colorless oil.  1H NMR (600 MHz, CDCl3):  
0.15 (s, 9H), 1.48-1.87 (m, 6H), 1.60 (s, 3H), 1.66 (s, 3H), 1.67 (s, 3H), 1.96-2.16 (m, 
8H), 2.90 (s, 2H), 3.51 (ddd, 1H, 4.9, 4.9, 10.5), 3.89 (ddd, 1H, J = 2.9, 8.0, 11.0), 4.02 
(dd, 1H, J = 7.4, 11.8), 4.23 (dd, 1H, J = 6.4, 11.9), 4.62 (t, 1H, J = 3.7), 4.79-4.94 (m, 
1H), 5.11 (t, 1H, J = 5.8), 5.35 (t, 1H, J = 6.4).  13C NMR (150 MHz, CDCl3):  0.3, 16.1, 
16.6, 19.8, 25.6, 26.5, 26.9, 30.1, 30.9, 32.3, 39.5, 39.8, 62.4, 63.8, 97.9, 104.9, 112.2, 
120.8, 124.2, 126.0, 129.7, 135.2, 140.4.  MS: calculated 402.30, found 403.33 [M+H]+. 
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(2E,6E,10E)-3,7,11-trimethyltetradeca-2,6,10-trien-13-yn-1-ol (alk-FOH-2): 
In a round-bottom flask equipped with a condenser, (7) (29 mg, 0.072 mmol) was 
dissolved in EtOH (2 mL).  Pyridinium p-toluenesulfonate (1.8 mg, 0.007 mmol) was 
added and the reaction mixture was stirred overnight at 60 °C.  The solvent was removed 
under reduced pressure and the crude material obtained was dissolved in THF (2 mL).  
Tetra-n-butylammonium fluoride (317 L of 1 M solution in THF, 0.317 mmol) was 
added and the reaction mixture stirred overnight at room temperature.  The solvent was 
removed under reduced pressure and the crude material obtained was purified by silica 
gel flash chromatography (20% EtOAc / 80% hexanes) to yield (alk-FOH-2) (13 mg, 
73%) as a colorless oil.  1H NMR (400 MHz, CDCl3):  1.60 (s, 3H), 1.68 (s, 6H), 1.86 
(s, 1H), 1.97-2.23 (m, 8H), 2.92 (m, 2H), 4.15 (d, 2H, J = 6.9), 5.12 (m, 1H), 5.41 (m, 
2H).  13C NMR (150 MHz, CDCl3):  13.6, 16.1, 16.4, 26.4, 27.2, 27.7, 39.4, 39.6, 59.6, 
78.0, 98.9, 110.3, 123.5, 124.3, 128.8, 135.1, 139.9.  MS: calculated 246.20, found 
247.25 [M+H]+. 
Trimethyl((5E,9E,13E)-5,9,13-trimethyl-15-((tetrahydro-2H-pyran-2-
yl)oxy)pentadeca-5,9,13-trien-1-yn-1-yl)silane (8): In a previously flame-dried round-
bottom flask under argon atmosphere was dissolved 1-(trimethylsilyl)propyne (88 mg, 
0.781 mmol) in anhydrous THF (1 mL) at -20 °C, and n-butyl lithium (488 L of 1.6 M 
solution in hexanes, 0.781 mmol) was added dropwise.  After 30 minutes, (6) (75 mg, 
0.195 mmol) dissolved in anhydrous THF (1 mL) was added dropwise, and the reaction 
mixture was allowed to slowly warm to 0 °C.  After stirring 12 hours at 0 °C, the reaction 
was quenched with ice-cold water (50 mL) and extracted with ether (3 x 50 mL).  The 
combined organic layers were washed with a saturated NaHCO3 aqueous solution (3 x 50 
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mL) and a saturated brine aqueous solution (150 mL), dried over Na2SO4, filtered and 
concentrated under reduced pressure.  The crude material was purified by silica gel flash 
chromatography (5% EtOAc / 95% hexanes) to yield (8) (77 mg, 94%) as a yellow oil.  
1H NMR (600 MHz, CDCl3):  0.13 (s, 9H), 1.46-1.76 (m, 6H), 1.56 (s, 3H), 1.60 (s, 
3H), 1.68 (s, 3H), 1.98 (t, 2H, J = 7.0), 2.00-2.14 (m, 6H), 2.18 (t, 2H, J = 7.6), 2.28 (q, 
2H, J = 6.9), 3.51 (ddd, 1H, J = 5.4, 5.4, 10.8), 3.89 (ddd, 1H, J = 2.5, 7.9, 10.9), 4.02 
(dd, 1H, J = 7.5, 11.6), 4.23 (dd, 1H, J = 6.4, 12.1), 4.62 (s, 1H), 5.10 (t, 1H, J = 5.6), 
5.15 (t, 1H, J = 6.6), 5.36 (t, 1H, J = 6.3).  13C NMR (150 MHz, CDCl3):  0.3, 16.0, 
16.2, 16.6, 19.4, 19.8, 25.7, 26.5, 26.8, 30.9, 38.8, 39.7, 39.8, 62.4, 63.8, 84.7, 98.0, 
107.6, 120.7, 124.1, 125.7, 133.5, 135.3, 140.4.  MS: calculated 416.31, found 439.42 
[M+Na]+. 
(2E,6E,10E)-3,7,11-trimethylpentadeca-2,6,10-trien-14-yn-1-ol (alk-FOH-3): 
In a round-bottom flask equipped with a condenser, (8) (63 mg, 0.151 mmol) was 
dissolved in EtOH (1.5 mL).  Pyridinium p-toluenesulfonate (3.8 mg, 0.015 mmol) was 
added and the reaction mixture was stirred overnight at 60 °C.  The solvent was removed 
under reduced pressure and the crude material obtained was dissolved in THF (1.5 mL).  
Tetra-n-butylammonium fluoride (332 L of 1 M solution in THF, 0.332 mmol) was 
added and the reaction mixture stirred overnight at room temperature.  The solvent was 
removed under reduced pressure and the crude material obtained was purified by silica 
gel flash chromatography (20% EtOAc / 80% hexanes) to yield (alk-FOH-3) (26 mg, 
67%) as a colorless oil, and was identical to previously reported 1H, 13C NMR and MS 
analyses[134].  1H NMR (600 MHz, CDCl3):  1.60 (s, 6H), 1.68 (s, 3H), 1.92-2.15 (m, 
9H), 2.17-2.29 (m, 4H), 4.15 (d, 2H, J = 6.9), 5.11 (t, 1H, J = 6.1), 5.17 (t, 1H, J = 6.9), 
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5.41 (t, 1H, J = 6.6).  13C NMR (150 MHz, CDCl3):  15.9, 16.1, 16.4, 17.8, 26.4, 26.7, 
38.5, 39.6, 39.7, 59.5, 68.5, 84.6, 123.5, 124.1, 125.7, 133.3, 135.3, 139.9.  MS: 
calculated 260.21, found 283.33 [M+Na]+. 
2-(((2E,6E,10E)-12-azido-3,7,11-trimethyldodeca-2,6,10-trien-1-
yl)oxy)tetrahydro-2H-pyran (9): In a round-bottom flask, (6) (75 mg, 0.195 mmol) was 
dissolved in DMSO (1 mL).  Sodium azide (19 mg, 0.293 mmol) was added and the 
reaction mixture was stirred overnight at room temperature.  The reaction was diluted 
with ice-cold water (50 mL) and extracted with ether (3 x 50 mL).  The combined organic 
layers were washed with a saturated brine aqueous solution (150 mL), dried over Na2SO4, 
filtered and concentrated under reduced pressure.  The crude material was purified by 
silica gel flash chromatography (5% EtOAc / 95% hexanes) to yield (9) (55 mg, 81%) as 
a yellow oil isomeric mixture, which was identical to previously reported 1H, 13C NMR 
and MS analyses.  1H NMR (600 MHz, CDCl3):  1.47-1.87 (m, 6H), 1.58 (s, 3H), 1.67 
(s, 3H), 1.72 (s, 3H), 1.91-2.21 (m, 8H), 3.50 (m, 1H), 3.63 (s, 1H), 3.79 (t, 1H, J = 7.0), 
3.88 (t, 1H, J = 9.4), 4.01 (t, 1H, J = 8.8), 4.23 (dd, 1H, J = 6.6, 11.8), 4.62 (s, 1H), 4.95 
(d, 1H, J = 23.5), 5.12 (m, 1H), 5.37 (m, 1H).  13C NMR (150 MHz, CDCl3):  14.8, 
(16.1), 16.6, 17.8, 19.8, 25.7, 26.4, (26.5), (30.8), 30.9, 36.1, 39.4, 39.7, 59.6, 62.4, 63.8, 
(68.2), 98.0, (114.7), 120.8, 120.9, (124.6), 125.1, 130.4, 134.0, 140.2, (140.3), (142.5).  
MS: calculated 347.26, found 370.42 [M+Na]+. 
(2E,6E,10E)-12-azido-3,7,11-trimethyldodeca-2,6,10-trien-1-ol (az-FOH) was 
produced according to published literature protocols and yielded an isomeric mixture of 
az-FOH, which was identical to previously reported 1H, 13C NMR and MS analyses.  1H 
NMR (400 MHz, CDCl3):  1.60 (s, 3H), 1.68 (s, 3H), 1.73 (s, 3H), 1.92-2.22 (m, 8H), 
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3.64 (s, 1H), 3.80 (t, 1H, J = 7.1), 4.15 (d, 2H, J = 6.8), 4.96 (d, 1H, J = 15.5), 5.13 (m, 
1H), 5.41 (t, 1H, J = 6.7).  13C NMR (150 MHz, CDCl3):  14.8, 16.1, 16.4, (17.8), 26.3, 
26.4, (26.5), (30.7), (36.1), (39.3), 39.5, 39.6, 59.5, 68.1, (114.7), 123.5, 123.6, (124.5), 
125.0, 130.4, 134.1, (134.8), 139.6, (139.8), (142.5).  MS: calculated 263.20, found 
264.25 [M+H]+. 
5.11.4 Biotin detection tag synthesis 
5-azido-N-(15-oxo-19-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-
d]imidazol-4-yl)-4,7,10-trioxa-14-azanonadecyl)pentanamide (az-biotin):  In a round-
bottom flask equipped with a magnetic stir bar was dissolved 5-azidopentanoic acid (140 
mg, 1 mmol) in CH2Cl2  (10mL).  N-methylmorpholine (121 mg, 1.2 mmol) and isobutyl-
chloroformate (163.8 mg, 1.2 mmol) were added, and this reaction mixture was stirred 
for 30 min at 0 °C.  Then, this solution of activated acid was transferred via a syringe to a 
solution of biotin-PEG-amine[54] (150 mg, 0.3 mmol) in DMF (10 mL) in another 
round-bottom flask equipped with a magnetic stir bar and stirred at room temperature for 
3 h.  The solvent was evaporated under reduced pressure and the crude mixture was 
purified by flash chromatography on silica gel (70% EtOAc / 20% MeOH / 10% H2O) to 
afford 76 mg of az-biotin as a white solid (45%).  1H NMR (400 MHz, CD3OD):  1.5 
(m, 2H), 1.6-1.8 (m, 12H), 2.2 (m, 4H), 2.7 (d, 1H, J = 12.7), 2.9 (dd, 1H, J = 4.8, 12.7), 
3.2 (ddd, 1H, J = 4.8, 7.4, 7.4), 3.3-3.4 (m, 6H), 3.5-3.7 (m, 12H), 4.3 (m, 1H), 4.5 (m, 
1H), 5.2 (br, 1H), 5.8 (br, 1H), 6.4 (br, 1H), 6.6 (br, 1H).  13C NMR (100 MHz, CD3OD): 
 19.5, 22.9, 23.2, 26.4, 26.6, 28.4, 28.7, 28.9, 36.2, 37.9, 51.5, 66.2, 68.5, 70.1, 168.03, 
168.04, 173.1.  MALDI-TOF: 572.5 [M+H]+. 
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5.11.5 Rhodamine detection tags synthesis 
N-(6-(diethylamino)-9-(2-(4-hept-6-ynoylpiperazine-1-carbonyl)phenyl)-3H-
xanthen-3-ylidene)-N-ethylethanaminium (alk-rho):  In a previously flame-dried 
under an argon atmosphere round-bottom flask equipped with a magnetic stir bar, was 
dissolved 6-heptynoic acid (6 mL, 0.050 mmol) in dry DMF (0.5mL).  1-1’-Carbonyl 
diimidazole (8 mg, 0.050 mmol) was added in one portion, and the reaction mixture was 
stirred at room temperature for one hour.  Rhodamine B piperazine amide[55] (24 mg, 
0.044 mmol) was then added in one portion and the reaction mixture was stirred at room 
temperature overnight.  The solvent was evaporated under reduced pressure and the crude 
mixture was purified by flash chromatography on silica gel (80% EtOAc / 13% MeOH / 
7% H2O) to afford 22 mg of alk-rho as a purple solid (76%).  1H NMR (600 MHz, 
CD3OD):  1.31 (t, 12H, J = 7.1), 1.46-1.57 (m, 2H), 1.61-1.71 (m, 2H), 2.15-2.25 (m, 
3H), 2.38 (t, 2H, J = 7.3), 3.4 (br, 8H), 3.70 (quartet, 8H, J = 7.1), 6.98 (d, 2H, J = 2.4), 
7.08 (dd, 2H, J = 2.4, 9.5), 7.29 (d, 2H, J = 9.5), 7.50-7.55 (m, 1H), 7.68-7.73 (m, 1H), 
7.76-7.80 (m, 2H).  13C NMR (100 MHz, CD3OD):  12.8, 18.7, 25.3, 29.1, 33.4, 42.7, 
46.0, 46.9, 69.9, 84.7, 97.4, 114.9, 115.4, 128.9, 131.2, 131.3, 131.8, 132.3, 133.2, 136.5, 
157.0, 157.2, 159.3, 169.6, 174.0.  LCMS: 619.55 [M]+. 
N-(9-(2-(4-(6-azidohexanoyl)piperazine-1-carbonyl)phenyl)-6-(diethylamino)-
3H-xanthen-3-ylidene)-N-ethylethanaminium (az-rho):  In a previously flame-dried 
under an argon atmosphere round-bottom flask equipped with a magnetic stir bar, was 
dissolved 6-azidohexanoic acid (8 mg, 0.050 mmol) in dry DMF (0.5mL).  1-1’-Carbonyl 
diimidazole (8 mg, 0.050 mmol) was added in one portion, and the reaction mixture was 
stirred at room temperature for one hour.  Rhodamine B piperazine amide[55] (25 mg, 
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0.046 mmol) was then added in one portion and the reaction mixture was stirred at room 
temperature overnight.  The solvent was evaporated under reduced pressure and the crude 
mixture was purified by flash chromatography on silica gel (80% EtOAc / 13% MeOH / 
7% H2O) to afford 22 mg of az-rho as a purple solid (70%).  1H NMR (600 MHz, 
CD3OD):  1.31 (t, 12H, J = 7.1), 1.34-1.48 (m, 2H), 1.53-1.68 (m, 4H), 2.36 (t, 2H, J = 
7.4), 3.3 (m, 2H), 3.40 (br, 8H), 3.69 (quartet, 8H, J = 7.1), 6.97 (d, 2H, J = 2.4), 7.08 
(dd, 2H, J = 2.4, 9.5), 7.28 (d, 2H, J = 9.5), 7.50-7.54 (m, 1H), 7.68-7.72 (m, 1H), 7.75-
7.80 (m, 2H).  13C NMR (150 MHz, CD3OD):  12.8, 25.8, 27.4, 29.7, 33.6, 42.7, 46.0, 
46.9, 52.3, 97.4, 114.9, 115.4, 128.9, 131.2, 131.3, 131.8, 132.3, 133.2, 136.5, 157.0, 
157.2, 159.3, 170.6, 174.0.  LCMS: 650.57 [M]+. 
5.11.6 Azido-azo-biotin cleavable tag for proteomics synthesis 
4-(2-azidoethyl)phenol (11).  To an ice-cooled suspension of NaN3 (546 mg, 
8.40 mmol) in CH3CN (10 mL) was slowly added Tf2O (1.17 mL, 7.00 mmol).  The 
mixture was stirred at 0 ºC for 2 h.  A solution of tyramine (10) (800 mg, 5.83 mmol) and 
ZnCl2 (79.3 mg, 0.58 mmol) in H2O:CH3CN (3:7) was added to the reaction mixture, 
followed by Et3N (2.40 mL, 17.5 mmol) and freshly prepared N3Tf.  The reaction was 
kept stirring at rt for 8 h.  The reaction mixture was then concentrated under vacuum, 
dissolved in EtOAc, and washed with H2O twice. The organic layers were collected, 
dried over MgSO4 and concentrated.  The crude product was purified by flash column 
chromatography (25% EtOAc in hexane) to give colorless 4-(2-azidoethyl)phenol (11) 
(915 mg, 5.61 mmol, 96%).  1H-NMR (CDCl3, 400 MHz): δ 7.08 (d, 2H, J = 8.4 Hz), 
6.78 (d, 2H, J = 8.4 Hz), 3.45 (t, 2H, J = 7.2 Hz), 2.82 (t, 2H, J = 7.2 Hz); 13C-NMR 
(CDCl3,100 MHz): δ 154.3, 130.1, 129.9, 115.4, 52.6, 34.4. 
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(E)-4-((5-(2-azidoethyl)-2-hydroxyphenyl)diazenyl)benzoic acid (12). Solid 
NaNO2 (3.30 g, 6.55 mmol) was added to an ice-cooled suspension of 4-aminobenzoic 
acid in 6M HCl (40 mL).  The resulting mixture was stirred at 0 ºC and turned into a 
yellow-colored solution.  In the meantime, dissolving 4-(2-azidoethyl)phenol (11) (1.19 
g, 7.30 mmol) in cooled THF (15 mL) at 0 ºC, and subsequently added K2CO3 to this 
solution to adjust pH to 8.  After 40 min, the diazonium salt solution was slowly added to 
compound 2 at 0 ºC, while the pH was kept around 8 by adding more K2CO3. Once the 
reaction was complete, removed all the solvents under vacuum.  The concentrated residue 
was then re-dissolved in ethyl acetate, and washed with acidified H2O (pH 2~3) for three 
times.  The organic layers were collected, dried over MgSO4 and concentrated.  The 
crude product was purified by silica gel flash column chromatography (33% EtOAc in 
hexane and then 10% MeOH in CH2Cl2) to give yellow-colored compound 12 (1.27 g, 
4.08 mmol, 56%).  1H-NMR (CD3OD, 600 MHz) δ: 8.24 (d, 2H, J = 8.5 Hz), 8.05 (d, 2H, 
J = 8.5 Hz), 7.89 (d, 1H, J = 1.9 Hz), 7.40 (dd, 1H, J = 8.3, 2.0 Hz), 7.04 (d, 1H, J = 8.4 
Hz), 3.61 (t, 2H, J = 7.0 Hz), 2.97 (t, 2H, J = 7.0 Hz); 13C-NMR (CD3OD, 150 MHz) 
δ:176.6, 163.9, 163.8, 148.3, 144.9, 140.4, 139.6, 132.5, 131.3, 128.2, 61.4, 43.3.  ESI-
MS calcd. for C15H13N5O3 [M-H]-: 310.0940, found 310.2. 
(E)-2,5-dioxopyrrolidin-1-yl 4-((5-(2-azidoethyl)-2-hydroxyphenyl)diazenyl) 
benzoate (13): To compound 12 (164 mg, 0.53 mmol) dissolved in anhydrous THF (20 
mL) was added DCC (119 mg, 0.58 mmol) and N-hydroxy-succinimide (66.7 mg, 0.58 
mmol) under Ar.  After the reaction was stirred at room temperature for 4 h and 
concentrated in vacuo.  The crude solid residue was then dissolved in chilled ethyl acetate 
and the urea was filtered off.  The filtrate was then concentrated and purified by silica gel 
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flash column chromatography (33% EtOAc in hexane) to give yellow-colored compound 
13 (170 mg, 79%).  1H-NMR (CDCl3, 600 MHz): δ 8.31 (d, 2H, J = 8.3 Hz), 8.00 (d, 2H, 
J = 8.3 Hz), 7.87 (d, 1H, J = 1.9 Hz), 7.31 (dd, 1H, J = 8.5, 2.0 Hz), 7.05 (d, 1H,  J = 8.5 
Hz), 3.60 (t, 2H,  J = 7.0 Hz), 2.95-2.98 (m, 6H); 13C-NMR (CDCl3,150 MHz): δ 169.1, 
161.2, 154.3, 151.7, 137.4, 135.3, 133.6, 131.9, 130.0, 126.6, 122.4, 118.7, 52.4, 34.2, 
25.7.  ESI-MS calcd. for C19H16N6O5 [M+H]+: 409.1260, found 409.3. 
(E)-4-((5-(2-azidoethyl)-2-hydroxyphenyl)diazenyl)-N-(15-oxo-19-(2-
oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10-trioxa-14-
azanonadecyl)benzamide (az-azo-biotin): To compound 13 (13 mg, 0.03 mmol) 
dissolved in anhydrous DMF (3 mL) was added biotin-PEG-amine[54] (27.0 mg, 0.06 
mmol).  The reaction was complete after stirring at room temperature for 10 h and 
concentrated.  The crude product was dissolved in CH3CN:H2O (1:1) and purified by 
reversed preparative HPLC column (CH3CN: 5% to 40% in 10 min, then 40% to 100% in 
40 min, az-azo-biotin was eluted at 33 min) to give yellow-colored product (18.0 mg, 
80%).  1H-NMR (CD3OD, 400 MHz): δ 8.44 (brs, 1H), 8.00 (brs, 4H), 7.83 (d, 1H, J = 
2.0 Hz), 7.33 (dd, 1H, J = 8.5, 2.0 Hz), 6.99 (d, 1H, J = 8.4 Hz), 4.46 (dd, 1H, J = 7.7, 5.0 
Hz), 4.27 (dd, 1H, J = 7.8, 4.4 Hz), 3.66-3.47 (m, 18H), 3.23 (t, 2H, J = 6.7 Hz), 3.16 (td, 
1H, J = 4.6, 9.2 Hz), 2.92 (t, 2H, J = 7.0 Hz), 2.68 (d, 1H, J = 12.7 Hz), 2.16 (t, 2H, J = 
7.3 Hz), 1.93 (t, 1H, J = 6.3 Hz), 1.89 (t, 1H, J = 6.3 Hz), 1.76-1.52 (m, 6H), 1.42 (t, 1H, 
J = 7.6 Hz), 1.38 (t, 1H, J = 7.7 Hz), 1.28 (brs, 2H), 0.89 (m, 1H); 13C-NMR (CD3OD, 
100 MHz): δ 175.9, 169.1, 166.1, 154.3, 153.3, 139.0, 137.8, 135.8, 131.8, 131.3, 129.6, 
123.4, 119.3, 71.5, 71.3, 71.2, 70.3, 63.3, 61.6, 57.0, 53.5, 41.0, 38.9, 37.8, 36.8, 35.1, 
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30.7, 30.4, 29.8, 29.4, 26.8.  MALDI-TOF calcd. for C35H49N9O7S [M+Na]+: 762.8744, 
found: 762.26. 
5.12 1H and 13C NMR spectra 
    
 
SpinWorks 2.5:  Standard One-dimensional 1H Experiment: alk-12
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
 
 
 
1
.
9
1
3
 
 
 
 
 
 
2
.
0
0
0
 
 
 
 
 
 
0
.
8
9
1
 
 
 
 
 
 
2
.
2
0
7
 
 
 
 
 
 
2
.
0
5
8
 
 
 
 
 
 
2
.
3
0
6
 
 
 
 
 
 
1
3
.
5
8
 
 
 
 
 
 
7
.
2
5
9
9
 
 
 
2
.
3
6
0
3
 
 
 
2
.
3
4
7
9
 
 
 
2
.
3
3
5
4
 
 
 
2
.
1
9
0
5
 
 
 
2
.
1
7
8
6
 
 
 
2
.
1
6
8
7
 
 
 
2
.
1
6
6
7
 
 
 
1
.
9
3
5
5
 
 
 
1
.
9
3
3
7
 
 
 
1
.
6
4
4
1
 
 
 
1
.
6
3
2
1
 
 
 
1
.
6
1
9
9
 
 
 
1
.
5
3
3
8
 
 
 
1
.
5
2
1
5
 
 
 
1
.
3
9
7
1
 
 
 
1
.
3
8
5
7
 
 
 
1
.
3
7
4
0
 
 
 
1
.
3
4
5
7
 
 
 
1
.
3
4
4
7
 
 
 
1
.
3
3
5
4
 
 
 
1
.
3
2
0
9
 
 
 
1
.
2
7
4
3
 
 
-
0
.
0
0
1
3
 
 
-
0
.
0
1
9
8
file: C:\Users\guill_2\Documents\Backup\Chemistry\NMR\600\alk-12\1\fid   expt: <zg30>
transmitter freq.: 600.112850 MHz
time domain size: 32768 points
width:  8389.26 Hz = 13.979474 ppm = 0.256020 Hz/pt
number of scans: 16
freq. of 0 ppm: 600.110018 MHz
processed size: 65536 complex points
LB:    0.000    GB: 0.0000
103
              
 
SpinWorks 2.5:  13C Direct Detection: alk-12
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SpinWorks 2.5:   Standard One-dimensional 1H Experiment: alk-14
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
 
 
 
2
.
0
0
0
 
 
 
 
 
 
1
.
9
9
8
 
 
 
 
 
 
0
.
9
0
9
 
 
 
 
 
 
2
.
1
2
1
 
 
 
 
 
 
2
.
0
5
3
 
 
 
 
 
 
2
.
1
5
6
 
 
 
 
 
 
1
6
.
5
6
 
 
 
 
 
 
7
.
2
6
0
0
 
 
 
2
.
3
5
9
1
 
 
 
2
.
3
4
6
6
 
 
 
2
.
3
3
4
0
 
 
 
2
.
1
9
2
5
 
 
 
2
.
1
8
8
1
 
 
 
2
.
1
8
0
6
 
 
 
2
.
1
7
6
2
 
 
 
2
.
1
6
8
7
 
 
 
2
.
1
6
4
3
 
 
 
1
.
9
3
7
5
 
 
 
1
.
9
3
3
1
 
 
 
1
.
9
2
8
7
 
 
 
1
.
6
4
3
9
 
 
 
1
.
6
3
1
8
 
 
 
1
.
6
1
9
4
 
 
 
1
.
5
3
4
5
 
 
 
1
.
5
2
2
0
 
 
 
1
.
5
0
9
5
 
 
 
1
.
3
9
7
9
 
 
 
1
.
3
8
5
9
 
 
 
1
.
3
7
3
7
 
 
 
1
.
3
3
6
1
 
 
 
1
.
3
3
1
9
 
 
 
1
.
3
3
1
0
 
 
 
1
.
3
2
0
8
 
 
 
1
.
2
7
0
1
 
 
 
1
.
2
5
9
4
 
 
 
0
.
0
1
0
2
 
 
 
0
.
0
0
9
3
 
 
 
0
.
0
0
8
4
 
 
 
0
.
0
0
4
3
 
 
-
0
.
0
0
1
1
 
 
-
0
.
0
0
6
4
 
 
-
0
.
0
1
3
2
 
 
-
0
.
0
1
4
0
 
 
-
0
.
0
1
4
9
 
 
-
0
.
0
1
5
8
 
 
-
0
.
0
1
6
6
file: C:\Users\guill_2\Documents\Backup\Chemistry\NMR\600\alk-14\1\fid   expt: <zg30>
transmitter freq.: 600.112850 MHz
time domain size: 32768 points
width:  8389.26 Hz = 13.979474 ppm = 0.256020 Hz/pt
number of scans: 15
freq. of 0 ppm: 600.110018 MHz
processed size: 65536 complex points
LB:    0.000    GB: 0.0000
105
       
 
SpinWorks 2.5:  13C Direct Detection: alk-14
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
 
1
7
9
.
6
3
3
5
 
 
8
4
.
9
7
4
2
 
 
7
7
.
3
7
1
6
 
 
7
7
.
1
6
0
0
 
 
7
6
.
9
4
8
5
 
 
6
8
.
1
7
2
0
 
 
3
4
.
0
8
7
8
 
 
2
9
.
7
2
6
8
 
 
2
9
.
6
4
4
7
 
 
2
9
.
5
7
2
1
 
 
2
9
.
3
8
5
2
 
 
2
9
.
2
5
9
6
 
 
2
9
.
2
0
9
0
 
 
2
8
.
9
1
7
9
 
 
2
8
.
6
5
5
4
 
 
2
4
.
8
3
1
6
 
 
1
8
.
5
5
3
7
 
 
 
0
.
1
4
1
7
file: C:\Users\guill_2\Documents\Backup\Chemistry\NMR\600\alk-14\2\fid   expt: <zgpg30>
transmitter freq.: 150.912869 MHz
time domain size: 65536 points
width: 36231.88 Hz = 240.084787 ppm = 0.552855 Hz/pt
number of scans: 828
freq. of 0 ppm: 150.897757 MHz
processed size: 32768 complex points
LB:    3.000    GB: 0.0000
106
     
 
SpinWorks 2.5:    Standard One-dimensional 1H Experiment: alk-16
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
 
 
 
2
.
0
0
0
 
 
 
 
 
 
1
.
9
8
5
 
 
 
 
 
 
0
.
8
6
9
 
 
 
 
 
 
2
.
1
0
4
 
 
 
 
 
 
2
.
0
4
3
 
 
 
 
 
 
2
3
.
0
3
 
 
 
 
 
 
7
.
2
6
0
0
 
 
 
2
.
3
5
9
0
 
 
 
2
.
3
4
6
6
 
 
 
2
.
3
3
3
9
 
 
 
2
.
1
9
2
2
 
 
 
2
.
1
8
7
8
 
 
 
2
.
1
8
0
2
 
 
 
2
.
1
7
5
9
 
 
 
2
.
1
6
8
3
 
 
 
2
.
1
6
3
9
 
 
 
1
.
9
3
8
7
 
 
 
1
.
9
3
4
2
 
 
 
1
.
9
2
9
9
 
 
 
1
.
6
4
3
3
 
 
 
1
.
6
3
1
2
 
 
 
1
.
6
1
8
8
 
 
 
1
.
5
3
3
8
 
 
 
1
.
5
2
1
5
 
 
 
1
.
5
0
8
7
 
 
 
1
.
4
9
6
6
 
 
 
1
.
3
9
6
8
 
 
 
1
.
3
8
4
8
 
 
 
1
.
3
7
2
5
 
 
 
1
.
3
4
5
1
 
 
 
1
.
3
4
4
3
 
 
 
1
.
3
3
5
2
 
 
 
1
.
3
1
9
9
 
 
 
1
.
2
7
1
2
 
 
 
1
.
2
5
3
4
file: C:\Users\guill_2\Documents\Backup\Chemistry\NMR\600\GCII-39\1\fid   expt: <zg30>
transmitter freq.: 600.127850 MHz
time domain size: 32768 points
width:  8389.26 Hz = 13.979124 ppm = 0.256020 Hz/pt
number of scans: 32
freq. of 0 ppm: 600.125014 MHz
processed size: 65536 complex points
LB:    0.000    GB: 0.0000
107
     
 
SpinWorks 2.5:   13C Direct Detection: alk-16
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:     Standard One-dimensional 1H Experiment: 4
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:    13C Direct Detection: 4
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:    Standard One-dimensional 1H Experiment: 5
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:   13C Direct Detection: 5
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:   Standard One-dimensional 1H Experiment: alk-FOH
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:  13C Direct Detection: alk-FOH
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SpinWorks 2.5:    Standard One-dimensional 1H Experiment: 6
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
 
 
 
0
.
7
7
8
 
 
 
 
 
 
0
.
8
3
8
 
 
 
 
 
 
0
.
8
9
9
 
 
 
 
 
 
1
.
0
0
0
 
 
 
 
 
 
0
.
9
6
3
 
 
 
 
 
 
1
.
2
5
5
 
 
 
 
 
 
1
.
5
4
3
 
 
 
 
 
 
1
.
2
3
1
 
 
 
 
 
 
1
.
0
7
3
 
 
 
 
 
 
8
.
0
8
5
 
 
 
 
 
 
2
.
4
9
6
 
 
 
 
 
 
7
.
0
1
4
 
 
 
 
 
 
8
.
2
0
2
 
 
 
 
 
 
7
.
2
6
0
0
 
 
 
5
.
5
6
6
2
 
 
 
5
.
5
5
5
4
 
 
 
5
.
5
5
4
5
 
 
 
5
.
5
4
3
6
 
 
 
5
.
5
4
2
8
 
 
 
5
.
3
5
6
4
 
 
 
5
.
3
5
4
4
 
 
 
5
.
3
5
2
4
 
 
 
5
.
3
4
5
8
 
 
 
5
.
3
4
3
9
 
 
 
5
.
3
4
2
1
 
 
 
5
.
3
3
5
5
 
 
 
5
.
3
3
3
5
 
 
 
5
.
3
3
1
5
 
 
 
5
.
1
0
7
0
 
 
 
5
.
1
0
5
0
 
 
 
5
.
0
9
5
8
 
 
 
5
.
0
9
3
8
 
 
 
5
.
0
8
6
1
 
 
 
5
.
0
8
4
2
 
 
 
5
.
0
8
2
2
 
 
 
4
.
6
1
5
2
 
 
 
4
.
6
0
8
1
 
 
 
4
.
6
0
2
8
 
 
 
4
.
2
3
6
1
 
 
 
4
.
2
3
5
0
 
 
 
4
.
2
2
5
4
 
 
 
4
.
2
2
4
4
 
 
 
4
.
2
1
6
3
 
 
 
4
.
2
1
5
2
 
 
 
4
.
2
0
5
6
 
 
 
4
.
2
0
4
6
 
 
 
4
.
0
2
6
7
 
 
 
4
.
0
1
4
4
 
 
 
4
.
0
0
6
8
 
 
 
3
.
9
9
4
6
 
 
 
3
.
9
8
3
5
 
 
 
3
.
9
5
9
0
 
 
 
3
.
9
4
9
1
 
 
 
3
.
8
9
4
3
 
 
 
3
.
8
8
9
8
 
 
 
3
.
8
8
1
6
 
 
 
3
.
8
7
6
0
 
 
 
3
.
8
7
1
0
 
 
 
3
.
8
6
2
9
 
 
 
3
.
8
5
7
4
 
 
 
3
.
5
1
2
0
 
 
 
3
.
5
1
0
4
 
 
 
3
.
5
0
5
6
 
 
 
3
.
5
0
3
4
 
 
 
3
.
5
0
1
3
 
 
 
3
.
4
9
4
0
 
 
 
3
.
4
8
8
9
 
 
 
3
.
4
8
6
6
 
 
 
3
.
4
8
4
6
 
 
 
3
.
4
8
2
7
 
 
 
3
.
4
7
6
1
 
 
 
2
.
1
2
2
6
 
 
 
2
.
1
1
0
6
 
 
 
2
.
0
9
8
1
 
 
 
2
.
0
8
5
6
 
 
 
2
.
0
7
0
5
 
 
 
2
.
0
6
1
4
 
 
 
2
.
0
4
5
1
 
 
 
2
.
0
3
1
5
 
 
 
2
.
0
2
0
1
 
 
 
2
.
0
1
0
8
 
 
 
1
.
9
9
7
6
 
 
 
1
.
9
8
5
4
 
 
 
1
.
9
7
1
9
 
 
 
1
.
9
6
7
0
 
 
 
1
.
9
6
4
6
 
 
 
1
.
9
6
2
4
 
 
 
1
.
9
0
4
8
 
 
 
1
.
8
4
4
1
 
 
 
1
.
8
3
4
5
 
 
 
1
.
8
3
3
4
 
 
 
1
.
8
3
2
3
 
 
 
1
.
8
3
1
1
 
 
 
1
.
8
1
9
6
 
 
 
1
.
8
1
3
9
 
 
 
1
.
8
0
8
3
 
 
 
1
.
8
0
6
3
 
 
 
1
.
8
0
1
8
 
 
 
1
.
7
9
9
0
 
 
 
1
.
7
9
1
7
 
 
 
1
.
7
8
9
8
 
 
 
1
.
7
8
4
5
 
 
 
1
.
7
7
8
4
 
 
 
1
.
7
6
3
2
 
 
 
1
.
7
5
5
3
 
 
 
1
.
7
5
1
8
 
 
 
1
.
7
5
0
0
 
 
 
1
.
7
4
5
1
 
 
 
1
.
7
4
4
2
 
 
 
1
.
7
3
3
3
 
 
 
1
.
7
3
2
3
 
 
 
1
.
7
3
1
4
 
 
 
1
.
7
1
9
6
 
 
 
1
.
7
1
3
1
 
 
 
1
.
7
0
7
9
 
 
 
1
.
7
0
2
5
 
 
 
1
.
6
9
7
8
 
 
 
1
.
6
9
1
2
 
 
 
1
.
6
8
7
6
 
 
 
1
.
6
8
0
9
 
 
 
1
.
6
7
5
3
 
 
 
1
.
6
7
2
4
 
 
 
1
.
6
7
0
2
 
 
 
1
.
6
6
1
3
 
 
 
1
.
6
4
7
3
 
 
 
1
.
6
3
3
1
 
 
 
1
.
6
2
6
3
 
 
 
1
.
6
2
4
2
 
 
 
1
.
6
1
8
6
 
 
 
1
.
6
1
7
0
 
 
 
1
.
6
0
9
7
 
 
 
1
.
5
9
7
6
 
 
 
1
.
5
8
9
5
 
 
 
1
.
5
7
7
6
 
 
 
1
.
5
6
8
4
 
 
 
1
.
5
6
3
4
 
 
 
1
.
5
6
0
3
 
 
 
1
.
5
5
6
3
 
 
 
1
.
5
5
4
2
 
 
 
1
.
5
4
9
4
 
 
 
1
.
5
4
3
6
 
 
 
1
.
5
4
0
2
 
 
 
1
.
5
3
4
3
 
 
 
1
.
5
1
7
3
 
 
 
1
.
5
1
3
7
 
 
 
1
.
5
0
6
7
 
 
 
1
.
5
0
4
8
 
 
 
1
.
5
0
2
6
 
 
 
1
.
4
9
7
9
 
 
 
1
.
4
9
6
0
file: C:\Users\guill_2\Documents\Backup\Chemistry\NMR\600\GCIII-65\1\fid   expt: <zg30>
transmitter freq.: 600.112850 MHz
time domain size: 32768 points
width:  8389.26 Hz = 13.979474 ppm = 0.256020 Hz/pt
number of scans: 12
freq. of 0 ppm: 600.110017 MHz
processed size: 65536 complex points
LB:    0.500    GB: 0.0000
115
     
 
SpinWorks 2.5:   13C Direct Detection: 6
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SpinWorks 2.5:   Standard One-dimensional 1H Experiment: 7
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:   13C Direct Detection: 7
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SpinWorks 2.5:   Standard one-dimentional 1H: alk-FOH-2
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SpinWorks 2.5:    13C Direct Detection: alk-FOH-2
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:    Standard One-dimensional 1H Experiment: 8
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:    13C Direct Detection: 8
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:   Standard One-dimensional 1H Experiment: Alk-FOH-3
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:   13C Direct Detection: Alk-FOH-3
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:   Standard One-dimensional 1H Experiment: 9
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SpinWorks 2.5:   13C Direct Detection: 9
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:   Standard One-dimensional 1H Experiment: az-FOH
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:   13C Direct Detection: az-FOH
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:   Standard one-dimentional 1H: az-biotin
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:  13C Direct Detection: az-biotin
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:  Standard One-dimensional 1H Experiment: alk-rho
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:  13C Direct Detection: alk-rho
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:    Standard One-dimensional 1H Experiment: az-rho
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:   13C Direct Detection: az-rho
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:   Standard One-dimensional 1H Experiment: 11
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:   13C Direct Detection: 11
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:   Standard One-dimensional 1H Experiment: 12
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:   13C Direct Detection: 12
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:   Standard One-dimensional 1H Experiment: 13
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:   13C Direct Detection: 13
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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SpinWorks 2.5:    Standard One-dimensional 1H Experiment: az-azo-biotin
PPM   8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
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SpinWorks 2.5:   13C Direct Detection: az-azo-biotin
PPM   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
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